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As the Regenstrief Center for Healthcare Engineering (RCHE) enters a new 
phase at Purdue University, our goal is to establish a clear vision and 
strategy for achieving national prominence for RCHE through its 
research programs and their impact. Purdue is strongly committed to 
the success of RCHE and is determined to provide the necessary 
leadership, resources, and planning to insure RCHE achieves its vision, 
fulfills its mission and becomes a source of pride for the Regenstrief 
Foundation. 
Leadership – President Daniels, realizing that more needed to be done to 
fulfill Purdue’s commitment to the Regenstrief Foundation and instill 
Foundation confidence and satisfaction in RCHE, charged one of his 
most valued and accomplished administrators, Executive Vice 
President for Research and Partnerships, Suresh Garimella with the 
responsibility of visibly and swiftly improving RCHE’s focus and 
impact. Dr. Garimella announced a national search for a new director 
in April 2015 and appointed Marietta Harrison as Interim Director of 
RCHE. Dr. Harrison has many years of administrative leadership 
experience with large and successful interdisciplinary research 
centers at Purdue and has the respect and enthusiastic cooperation 
of RCHE faculty and staff, as well as campus-wide administrators and 
faculty who are anxious to contribute to RCHE’s future success.  
Resources – Purdue is sincerely committed to significantly and rapidly 
growing faculty interest and eager participation in defining and 
leading RCHE programs as we move forward. We will fulfill our pledge 
to hire at minimum five new RCHE faculty and a commitment for five 
faculty lines has been received from the Dean of Engineering. We are 
equally committed to establishing a cohesive identity for RCHE 
faculty, staff and students and will obligate the needed additional 
space in Mann Hall in Discovery Park to facilitate such an identity and 
co-working culture.  
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The Way Forward – The search committee for the new director has been 
appointed and is chaired by George Wodicka, Head of the Weldon School of 
Biomedical Engineering. In addition to Dr. Wodicka, engineering is 
represented by faculty from the schools of chemical and industrial 
engineering.  A complete list of the search committee members is provided 
in Appendix G. The goal is to have a new director identified by the middle or 
end of the 2015 fall semester.  In the meantime, we will actively pursue two 
parallel paths to launch RCHE into the next phase of its evolution. First, we 
will build on the clear success of the Infusion Pump Informatics (IPI) 
“Community of Care” system and substantially increase the capacity and 
capabilities of the RCHE informatics HUB, CatalyzeCare, to support the 
creation of a new entity, the Regenstrief National Center for Medical Device 
Informatics. Second, we will begin a campus-wide dialog “building on 
RCHE’s strengths and defining new directions” through a series of “RCHE 
Idea Forums” that will take place over the summer. The Krannert School of 
Management, under the leadership of newly appointed Dean David 
Hummels has convened a summer brown bag series on “Healthcare” in an 
effort to identify and coalesce management faculty interested in defining 
and driving new research programs in RCHE. There is palpable excitement as 
the campus anticipates new opportunities to boost the “healthcare 
engineering” enterprise at Purdue.  
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How RCHE defines healthcare engineering 
 
The definition of Healthcare Engineering is in many ways in the “eyes of the 
beholder.”  RCHE approaches Healthcare Engineering as a “systems 
engineering” problem with a focus on healthcare delivery. There is no 
shortage of national opinions on what is wrong with the current US 
healthcare system as well as on strategies for how to fix it. RCHE aims to 
earn a leading voice in the national conversation through the impact of its 
research. RCHE sees its mission as creating and orchestrating the healthcare 
engineering enterprise at Purdue to influence the delivery of care. Purdue 
engineering programs enjoy national as well as international prominence.  
Engineering needs to be the foundation on which RCHE rests for that is 
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where Purdue and the Regenstrief Foundation can make unique and highly 
valued contributions. As with all grand challenges, lasting and impactful 
solutions will not come from a single discipline, and that is why the major 
engineering gear driving RCHE’s healthcare engineering system is meshed 
with other strong disciplines at Purdue. RCHE’s greatest asset is its faculty, 
and as those faculty generate ideas and projects they will have the RCHE-
supported network and resources to expand into the interdisciplinary space 
that is necessary to achieve real influence. The gears are all currently 
machined, the challenge is to get them to perfectly mesh and generate the 
power to drive the strong RCHE programs that will result. RCHE views 
Healthcare Engineering as the collection and analysis of data that results in 
the generation of new tools and devices that will drive improvements in 
healthcare delivery resulting in improved patient outcomes and increased 
patient safety.  
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What RCHE will be known for 
 
Vision: to become a national resource for the improvement of healthcare delivery 
Mission: to harness the intellectual strengths of current and future Purdue 
faculty to collaboratively drive the interdisciplinary healthcare 
engineering enterprise at Purdue University 
RCHE currently is recognized for its national leadership in infusion pump alert data 
analyses. The number of hospitals contributing data to and generating 
reports from RCHE’s CatalyzeCare HUB has risen from 10 (located only in 
Indiana) in 2010 to 123 (located nationally) as of May 2015. 
“In June 2013, the Joint Commission approved new National Patient 
Safety Goal NPSG.06.01.01 on clinical alarm safety for hospitals and 
critical access hospitals. In Phase I (beginning January 2014) hospitals 
will be required to establish alarms as an organizational priority and 
identify the most important alarms to manage based on their own 
internal situations. By 2016 hospitals will be expected to develop and 
implement specific components of policies and procedures. Education 
of those in the organization about the alarm system management will 
also be required.” Joint Commission Perspectives®, July 2013, Volume 33, 
Issue 7 
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Realizing that alarm safety was an emerging concern among hospital 
administrators and national regulatory organizations, RCHE focused 
attention on this escalating patient safety issue in 2010 before it reached 
the level of high national awareness. Using Purdue HUB technology 
(developed through a $38 million investment from the National Science 
Foundation), RCHE established a HIPAA-aligned HUB 
(www.CatalyzeCare.org) as a portal to support an internet accessible, 
national “Drug Limit Alert” database.  Currently (May 2015) 123 hospitals 
across the nation deposit alert data from smart pumps delivering IV drugs to 
patients into CatalyzeCare and generate comparative reports summarizing 
their hospital’s alert data relative to other hospitals in the database. Most 
importantly, the reports are used in real-time to identify candidate drugs for 
in-house changes to the “drug limit libraries” that hospital pharmacists 
generate to program smart pumps delivering drugs. This resource has grown 
dramatically since its inception and during the last four months alone 
growth has averaged eight new hospitals per month. Collectively, this 
“Community of Practice” is known as the RCHE Infusion Pump Informatics 
(IPI) System. RCHE sponsors three national conferences a year, one in-
person and two “virtual,” for this IPI community. The in-person conference 
is held at various venues throughout the Midwest and is attended by 
pharmacists, nurses and representatives of various national organizations 
who have an interest in infusion pump safety. Given the Joint Commission’s 
edict on alarm management, it is not surprising that the Association for the 
Advancement of Medical Instrumentation (AAMI), the American Society of 
Health-System Pharmacists (ASHP), and the Institute for Safe Medication 
Practices (ISMP) all have contacted RCHE to explore: 1) significantly 
expanding IPI’s capabilities, and 2) establishing a national standard for 
infusion medication.  
AAMI, in particular, is eager for RCHE to expand CatalyzeCare to support not only 
all smart pump alert data (currently CatalyzeCare only houses drug alert 
data, which represents approximately 10 percent of all alert data), but to 
significantly increase its capabilities to support and analyze physiologic 
sensing data from various hospital-based medical devices. RCHE is 
tremendously excited by this opportunity and plans are rapidly developing 
with the Purdue HUB development team to begin this expansion process. 
Our vision is to create and launch the Regenstrief National Center for 
Medical Device Informatics within RCHE by September 2015 and have it 
fully operational by the end of 2016.  
The IPI project and its planned expansion is the foundational example of “what 
RCHE will be known for.” IPI has already spawned novel research directions 
at Purdue resulting in the “Best Paper Award” from the Academy of 
Management for Dr. Benjamin Dunford’s “The Organization Made Us Do It: 
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Demanding Formalization and Workaround Attributions,” an organizational 
theory-based analysis of nurse workarounds to “smart pump alert fatigue.” 
This is an excellent example of the potential of the RCHE healthcare 
engineering enterprise, and much more is expected to follow with the 
acquisition of substantially more and larger annotated datasets (including 
patient conditions and outcomes). Not only will RCHE’s vendor partnerships 
(currently limited to smart pump manufacturers) greatly expand, but we 
envision creating new partner opportunities for providers of healthcare 
information technologies, such as the Cerner Corporation with whom we 
are in current discussions. All this will lead to a stronger, more 
comprehensive and powerful research resource for the center and its 
faculty.  
 
The planned extensive expansion of CatalyzeCare will increase the capacity for 
data storage and analysis by at least 1000 fold and will provide a coveted 
resource for RCHE faculty and staff as well as a catalyst for national 
standardization of medical instrumentation data. In 2015, RCHE became one 
of only 84 Patient Safety Organization designees and one of only two in 
Indiana, initially allowing for the confidential deposition of additional IPI-
related data into CatalyzeCare.  
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How RCHE will get there:  the roadmap 
 
The process for selecting a new director for RCHE began with the first meeting of 
the search committee on May 19, 2015. The plan is to formally advertise the 
position in early June and to immediately begin to generate a list of 
potential candidates from the individual networks of the search committee 
members with the goal of generating a rich and diverse pool of outstanding 
candidates. The committee is ably assisted by an executive recruiter from 
Purdue’s Talent Acquisition Team, which provides assistance for mission-
critical positions at the university. On-campus interviews are expected to 
begin in August with a new director on board by the middle to end of the fall 
semester.  
RCHE will continue to move forward rapidly on two parallel fronts as the search 
process progresses. The first is the establishment of the Regenstrief 
National Center for Medical Device Informatics and the accompanying major 
expansion of the HUB capabilities of CatalyzeCare to support the national 
medical device data that will be the foundation of the Center. The second is 
the convening of campus-wide “RCHE Idea Forums” to engage faculty in 
identifying and leading major research programs within RCHE. 
The substantial extension of the capabilities of CatalyzeCare was enthusiastically 
embraced by Purdue’s Vice President for Information Technology & Chief 
Information Officer who has responsibility for the HUB development team. 
He is currently in the process of identifying a senior member of his staff to 
oversee and drive the technology development that will be needed to house 
not only a tenfold increase in smart pump alert data, but the addition of 
drug interaction alert data, other medical device alert data as well as 
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physiological sensing data from monitors and ventilators. The latter will 
demand new technology design as data from monitors and ventilators are 
quite complex compared with alert data from smart pumps and in this 
regard we envision engaging Purdue engineers and computer scientists with 
our HUB development team to design and develop the needed capabilities.  
Serious discussions are ongoing between RCHE and the Departments of 
Biomedical Engineering and Computer Science regarding the establishment 
of a Medical Cyber-physical System Laboratory to support the Regenstrief 
National Center for Medical Device Informatics. The vision is to establish 
both physical and virtual spaces where next generation medical alert and 
monitoring devices will be designed and integrated with wireless sensor 
networks and other cyber components to form advanced analytical systems 
for healthcare applications. A key component of this vision is the generation 
of a business model where a pre-competitive space is established to attract 
vendors who wish to support next generation basic technology development 
in the medical device arena. The generation of this model will fall under the 
responsibilities of the Center’s new External Advisory Council discussed 
below. 
A critical element of success for the proposed Regenstrief National Center for 
Medical Device Informatics will be the formation of an External Advisory 
Council to guide the Center through its initial and long-term planning 
process, a major focus of which will be on the development of a long-term 
sustainability model. The External Advisory Council’s composition is 
envisioned to include representatives from national organizations that have 
relationships with RCHE (AAMI, ASHP, ISMP), representatives from relevant 
vendors (device manufacturers, healthcare informatics companies), and 
representatives from key constituents (healthcare systems administrators). 
This council will play a pivotal role in the Center’s development and ultimate 
success and we will engage the necessary Purdue assets (from the President 
to critical Deans) to recruit appropriate individuals of high national stature.  
Campus-wide “RCHE Idea Forums” are planned for the summer to engage faculty 
in lively and thought-stretching discussions to seek areas of critical mass 
interest and seed ideas to funnel into the RCHE healthcare engineering 
machine. The first forum will center on the vision for the Regenstrief 
National Center for Medical Device Informatics, while subsequent forums 
will be more open ended. The faculty leadership teams that arise from these 
forums will form the nexus of RCHE’s planned Internal Advisory Committee. 
The “RCHE Ideas Forum” resulted from many intellectually stimulating and 
uplifting meetings Dr. Harrison held with various department heads, Center 
leaders and individual faculty regarding RCHE’s future.  
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There was no shortage of ideas, excitement and support for this new phase 
in RCHE’s evolution. The Krannert School of Management, the School of 
Biomedical Engineering, and the Department of Statistics in particular are 
enthusiastic to become more deeply involved with RCHE and contribute to 
its future successes. All are represented on the RCHE Director Search 
Committee and are dedicated to finding a new director who will lead  
RCHE’s research to outcomes with high national impact. 
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Evidence-Based Communities of Practice 
CatalyzeCare.org:  An enabler to national communities of 
practice – Infusion Pump Informatics System 
The Regenstrief Center for Healthcare Engineering (RCHE) is using a community of practice approach, 
where focused groups of healthcare providers, vendors, researchers and others share knowledge and 
best practices, to improve healthcare delivery safety, efficacy, and efficiency. 
Background 
Communities of practice are groups of people who share a concern, a set of problems, or a passion about 
a topic, and who deepen their knowledge and expertise in this area by interacting on an ongoing basis.1  
A community of practice has three fundamental elements: a domain of knowledge, which defines a set of 
issues; a community of people who care about the domain; and the shared practice that they are 
developing to be effective in their domain.2 
RHCE builds on this concept by adding a decision support tool as a fourth requirement.  Members of the 
community provide data to the decision support tool and, using the reports and analytics capabilities, can 
examine their own and others’ data.  The resulting organizational structure is referred to as an evidence-
based community of practice. 
To assist communities of practice, RCHE launched CatalyzeCare in 2009. CatalyzeCare is a web-based hub 
for patients, providers, and researchers interested in improving healthcare delivery to interact online and 
collaborate on projects. Its secure environment allows geographically disperse research groups to co-
develop concepts and share results.   
IPI 
The first evidence-based community of practice formed by RCHE was Infusion Pump Informatics (IPI) in 
2008.  The IPI community was formed at the request of the Indianapolis Coalition for Patient Safety in 
response to a dosing error at one of their member hospitals.  The vision of the IPI community is, “To be a 
vibrant, resourceful and collaborative community that advances and promotes infusion pump medication 
administration in the interest of patient safety and quality.”  The IPI community is composed of a mixture 
of researchers and healthcare delivery providers, primarily pharmacists and nurses, representing more 
than 65 hospitals.  The IPI community shares practice knowledge by posting documents and discussions 
on CatalyzeCare and by holding a minimum of 3 conferences per year.  As an example of knowledge 
sharing, hospitals make their drug dosing libraries available to other hospitals for review and comparison.  
Additionally, IPI community members share their infusion pump alert data.  These data are viewed via an 
RCHE developed application providing hospital members the ability to analyze their own alert data and 
see how results compare to other IPI member hospitals.    
  
1 Cultivating Communities of Practice:  A Guide to Managing Knowledge. E. Wenger, R. McDermott, W. M. Snyder. 
2 ibid 
2015 Board Report Regenstrief Center for Healthcare Engineering
17
Today 
The IPI community is alive and well as alarm fatigue continues to be a problem for nurses in the clinical 
environment.  Alarm hazards were identified as the number 1 hazard for 2014 by the ECRI institute. New 
members are being added on a regular basis. Intermountain Healthcare of Utah was the latest member 
hospital to be added.  Support for a third pump vendor, Baxter, was added in April 2015. The Spring 2015 
IPI Conference was held in April at the University of Iowa and over 30 clinicians and researchers attended 
to view presentations and exchange knowledge.  The IPI community is recognized nationally as a leader 
in infusion pump safety and is actively involved in national projects like the National Coalition for Infusion 
Therapy Safety that gets support, in addition to RCHE, from the Joint Commission, the American 
Association of Critical-Care Nurses (AACN), the National Patient Safety Foundation (NPSF), and others.  
The value of an evidence-based community of practice approach has been recognized by the Agency for 
Healthcare Quality and Research (AHRQ) with the listing of Purdue as a Patient Safety Organization 
allowing the knowledge from the IPI community to be applied and disseminated nationally. 
Future 
RCHE will continue to use evidence-based communities of practice as a way to positively impact the 
safety and quality of healthcare delivery as well.  Future plans including 1) expanding the IPI community 
of practice to capture all infusion pump alerts, not just those generated from the drug limit library, 2) 
linking pump data to patient data to better measure impact, and 3) build a drug limit library comparison 
tool allowing clinicians to find and compare limits more easily and quickly.   
There are also plans to expand the evidence-based community of practice approach to other domains.  
RCHE is actively working to build new communities focused around other medical devices including 
physiological monitors, ventilators, and patient-controlled analgesia (PSA). 
These new communities will provide a fertile ground for Purdue researcher allowing research focused on 
specific medical devices, but also research on communities of practices themselves. 
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Patient Safety Organization 
 
The Patient Safety and Quality Improvement Act of 2015 was 
developed and enacted in response to the Institute of Medicine 
report, “To Err Is Human,” which generated national concern with 
the number of preventable medical errors that were occurring.  
By providing privilege and confidentiality protections to hospitals 
working with patient-safety organizations (PSOs), the act was intended to promote shared learning to 
enhance quality and safety nationally.  The Agency for Healthcare Research and Quality (AHRQ) is 
responsible for the regulation of PSOs. 
 
Need 
The Regenstrief Center for Healthcare Engineering (RCHE) approached AHRQ with the idea of becoming a 
PSO, using the Infusion Pump Informatics (IPI) evidence-based community of practice as a source for 
knowledge and best practices to improve the quality and safety of infusion-pump administration.  AHRQ 
supported the unique PSO model and encouraged RCHE to apply for listing as a PSO.  
Objective 
RCHE sought designation as a PSO to gain several beneficial strategies. 
Approach 
RCHE submitted an application and the Regenstrief Center for Healthcare Engineering at Purdue 
University Patient Safety Organization (RCHE Purdue PSO) was officially listed as a PSO on February 19, 
2015.  There are 84 total PSOs listed on the AHRQ PSO site, and RCHE Purdue PSO is one of two in Indiana 
(See http://www.pso.ahrq.gov/listed). 
Potential Impact 
With its new designation, the RCHE Purdue PSO benefited in the following ways: 
• To be invited and participate in AHRQ’s development of national strategies to improve patient 
safety and associated research strategies. 
• Demonstrate the impact of the infusion-pump informatics system and associated research for the 
Regenstrief Foundation. 
• Provide a means of receiving protected health information and furthering Purdue research, 
consistent with PSO regulations. 
• Create visibility with AHRQ as an innovator in patient-safety research and improvement.  AHRQ is 
a targeted national funding source for RCHE research. 
RCHE Purdue PSO will allow healthcare providers to voluntarily report information on patient-safety 
events under legal protection and to use this information to develop patient-safety interventions and 
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solutions in IV medication administration.  We believe this is an excellent example of using Purdue 
research to provide value to our extended community. 
Partners 
Dan Degnan, Purdue Center for Medication Safety Advancement, College of Pharmacy, Purdue University  
Researchers 
Richard Zink, Regenstrief Center for Healthcare Engineering, Purdue University 
Current Status 
Current activities include attending the 7th Annual PSO meeting in April and executing PSO contracts 
between hospital providers and RCHE. 
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National Coalition for Infusion Therapy Safety 
 
In 2010, the Association for the Advancement of Medical 
Instrumentation (AAMI) and the Food and Drug Administration (FDA) 
held an Infusion Device Summit to identify patient-safety issues 
related to infusion-pump administration management.  The 
deliverable from the summit was a 48-page document, “Infusing 
Patients Safely,” that identified 13 priority issues that needed to be 
addressed. 
AAMI organized and formed the National Coalition for Infusion Therapy 
Safety to address the ongoing patient-safety issues identified in the 
AAMI/FDA Infusion Device Summit.  The two-year initiative has the 
following goals:3 
1. To bring together pioneering hospitals, researchers, professional societies, industry, and other 
national leaders in infusion safety to agree upon evidence-based solutions to several key issues 
contributing to poor patient outcomes with infusion therapy. 
2. To promote those solutions nationwide through a variety of modalities and via a range of 
educational materials. 
The coalition is taking a phased approach to address the priority issues.  The initial phase was a coalition 
kickoff event in March 2015 where key stakeholders (hospitals, patient advocates, national organizations 
and societies, regulators, and industry partners) gathered to build consensus and share knowledge.  The 
second phase is to create multimedia campaigns to disseminate knowledge.   Deliverables from phase 1 
include conference proceedings, and phase 2 deliverables will be webinars, publications, event-based 
outreach, and web-based directories.   
The expectation is the data-driven results and strategies to overcome lack of compliance with drug 
libraries and the creation of educational materials for administering multiple-line infusions will improve 
patient safety.   
The Regenstrief Center for Healthcare Engineering (RCHE) has two roles in the coalition. The first role is 
as a thought leader in compliance with drug libraries.  The IPI community is a rich source of knowledge 
and best practices for improving drug-library compliance.  In the second role, AAMI has requested RCHE 
to provide project management for phase 2.  Additional opportunities might include a role for DLRC to 
create and disseminate educational and training materials.  
3 National Coalition for Infusion Therapy Safety—The Foundation—Association for the Advancement of 
Medical Instrumentation, http://www.aami.org/thefoundation/content.aspx?ItemNumber=1781, April 
14, 2015. 
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Health Systems Engineering Alliance 
 
Need 
The joint Institute of Medicine and National Academy of Engineering report on “Building a Better 
Delivery System:  A New Engineering/Health Care Partnership” called for the establishment of 
“multidisciplinary centers at institutions of higher learning throughout the country capable of 
bringing together researchers, practitioners, educators, and 
students from appropriate fields of engineering, health 
sciences, management, social and behavioral sciences, and 
other disciplines to address the quality and productivity 
challenges facing the nation’s health care delivery system.”  
It was recommended that these centers have a three-fold 
mission: 
1. Conduct basic and applied research on healthcare delivery. 
2. Perform technology transfer on the use of systems-engineering tools throughout the 
healthcare delivery system. 
3. Educate future engineering professionals and researchers. 
Unfortunately, the reality is the vast majority of universities do not have the necessary critical mass 
of faculty to accomplish this, yet collectively we do.  In response to this need, the Health Systems 
Engineering Alliance (HSEA) was formed. 
Objective 
Accelerate the development of health-systems engineering academic programs by providing a forum 
for sharing ideas, material, and lessons learned on both teaching and research about health-systems 
engineering. 
Approach 
The Regenstrief Center for Healthcare Engineering (RCHE) hosts a hub (https://catalyzecare.org/hsea) 
that provides a platform for these exchanges and represents yet another example of RCHE’s 
community-of-practice approach to dissemination. 
Potential Impact 
The opportunity is for a professional cultural change in the use of systems-engineering tools and 
information technologies within the healthcare community and to advance the training and 
development of healthcare, engineering, and management professionals with applications within this 
domain.  
Partners 
27 universities across the United States, Canada, and Mexico 
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Researchers 
Various engineering faculty from the above universities 
Current Status 
HSEA’s focus has been initially on educationsharing health-systems engineering course materials, 
student activities, degree/track designs, internship formats, employment opportunities, and faculty–
student exchanges.  This year the alliance can report the following achievements: 
1. Coordinated a five-session track at the INFORMS 2014 Conference 
2. Posted information on 14 courses and 33 degree/certificate programs in the group’s archives 
3. Hosted an international webinar on the 10-year evolution of a health-systems engineering 
course at the University of Wisconsin 
4. Advanced a health-systems engineering scholarship program with proposed funding from the 
Association for the Advancement of Medical Instrumentation (AAMI). 
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The research summaries described in this appendix provide additional details of 
RCHE’s current research activities.  A subset of these projects will form the 
basis for RCHE’s new research initiatives and will become more integrated as 
RCHE transitions its research focus. 
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About the Project Summaries 
 
The project summaries provide general information about RCHE’s projects.  The 
guides below indicate key features of the project table on the next two 
pages: 
1. Project Title 
2. Page number 
3. Research-to-Impact phase in which the project is currently working  
 
 








A.  Healthcare system evaluation 
with stakeholder input 
B. Research and model 
development 
C. Single-site pilot study and 
evaluation 
D.  Multiple-site pilot study and 
evaluation 
E.  Dissemination and evaluation 
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Project Title   Page Research-to- 
Impact Phase 
A B C D E 
Rating Healthcare 37      
System Impact Measures 39      
Smart Infusion Pump Alert Threshold Decision Support 44      
Nursing Attitudes and Perceived Causes of IV Pump Workarounds 46      
Development of the Infusion Pump Informatics System 51      
Supporting Communities of Practice to Improve Healthcare Delivery 53      
Improving Primary Care Delivery Through Allocation of Resources 55      
Hospital Readmissions (Pilot:  BayCare) 57      
All-Cause Unplanned and Preventable Readmissions Reduction 68      
Population Health Management Modeling to Support Accountable Care Delivery 
(Pilot: OurHealth) 
71 
     
Population Health Management Modeling to Support Accountable Care Delivery 
(Pilot: St. Vincent Health) 
74 
     
Affecting Cancer Together 76      
See-What-I-Do:  Increasing Mentor and Trainee Sense of Co-Presence in Trauma 
Surgeries with the STAR Platform 
78 
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Project Title   Page Research-to-
Impact phase 
A B C D E 
Improving Medication Adherence through Practitioner and Patient Health Literacy 
Education 
80 
     
Comparative Effectiveness of Different Implementations of the Patient Centered 
Medical Home Model in Rural Indiana 
82 
     
Wellness Coaching Impact on Employee Health Outcomes 84      
Bundled Payments 86      
Development of Physiological Monitor Databases 92      
Transitions in Care Pilot:  Evaluate the Impact of Electronic Communications 95      
Drug Limit Library Database and Research 100      
Drug Limit Library Update Process 103      









Faculty Tzuong-tsieng Moh, Department of Mathematics, Purdue University 
Staff PI:  Ping H. Huang, Regenstrief Center for Healthcare Engineering, 
Purdue University 
Healthcare Partners OurHealth 
Research Direction 
Competencies Mathematical modeling 
Research-to-Impact Phase B (Research and model development) 
Research Timeline June 2013–May 2016 
Project Summary 
Healthcare Problem  On-site clinics administer a predefined set of primary-care services to 
contracted organizations.  They agree to be accountable for the 
quality, appropriateness, and cost of this care for the members of 
these organizations and their dependents.  As such, they face a broad 
assortment of healthcare challenges, from managing the preventive-
care needs of their low-risk patients to providing referral guidance for 
their chronically ill patients.   
While these on-site clinics are asked to improve on their population’s 
overall health, it is impractical for them to continuously manage every 
patient.  Healthcare analytics are required to support these providers 
with the information they need to assess and stratify their patients.  
Armed with this information, they are better able to manage their 
patients’ health, properly integrate with other healthcare providers, 
drive better health outcomes, and decrease overall healthcare costs 
for not only their patients but their contracted organizations.   
Research Objectives Apply emerging mathematical-modeling techniques for multicriteria 
ranking and assess the effectiveness of the ranking method in its 
ability to assist in healthcare decision making.  Key analytical 
requirements include the ability to measure a population’s overall 
health, as well as the relative health of the patients within that 
population.   
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Methodology The methodology centers on creating a pairwise comparison matrix 
and uses its limiting power to produce a unique characteristic root 
that is reflective of each alternative’s relative rating. 
Potential Impact While the initial application of this methodology is in healthcare, it 
has the potential for much broader impact, in that any problem 
involving the evaluation of decision alternatives over multiple criteria 
is a candidate for this approach.  Its significant strengths include 
scalability (e.g., number of criteria, population size), discrimination 
power, nonweighted and nonlinear approach, and ability to work with 
missing data.  
Project Update                                     PATENT PENDING 
A technology disclosure process has been initiated with Purdue’s 
Office of Technology Commercialization (OTC).  Based on a thorough 
review of the pairwise comparison matrix methodology’s usefulness, 
novelty, and nonobviousness, OTC decided to submit a provisional 
patent to secure the methodology’s patentability and provide 
additional time to explore its commercial feasibility.   
Other developments include:  
• A manuscript titled “A non-linear non-weight method for multi-
criteria decision making “ was submitted to Annals of Operations 
Research on 1/29/2015. 
• A presentation on “Assessing Patient and Population Health in 
Support of Accountable Care” was given at the IIE Annual 
Conference 2015 on 5/31/2015. 
• The methodology has been applied to the analysis of OurHealth’s 
population-health status.  See the project summary titled:  
“Population Health Management Modeling to Support 
Accountable Care Delivery (Pilot:  OurHealth).”  
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System Impact Measures 
 
Research Team 
Faculty/Staff  PI:  Poching DeLaurentis,  
Regenstrief Center for Healthcare Engineering, Purdue University 
Healthcare Partners  UW Health 
Eskenazi Health 
Research Direction 
Competencies Data mining 
Pattern and clustering analysis 
Research-to-Impact Phase B (Research and model development) 
Research Timeline August 2014–March 2015 
Project Summary 
Healthcare Problem The Infusion-Pump Informatics (IPI) System serves as a novel infusion-
care, decision-support tool for pharmacists and nurses in the hospital 
setting.  The infusion-drug alerts data and knowledge sharing within 
this IPI System-forged community of practice, along with the various 
charting and report tools on the system, provide clinicians with in-
depth information on the infusion practice in each of the participating 
hospitals. From the viewpoints of the community coordinator and 
designer, it is important to understand and identify what drug-alert 
and user-usage patterns and clinical consequences may be linked and 
qualified as an impact of the adoption of the IPI System. 
Research Objectives For each selected hospital in the community, we start with four 
impact measures, as follows.  
1. Analyze the top 10 drugs over time; identify drugs of most 
interest by individual hospitals and the community as a whole. 
2. Analyze the reduction in the number of alerts per device per drug 
of interest and its change over time, including their movement in 
the top 10 drugs. 
3. Analyze the number and timing of drug-limit library updates, and 
identify their potential impact on items in 1 and 2 above. 
4. Analyze the compliance percentage over time (by hospital), 
compliance-view activities and compliance-relevant changes 
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made in the drug library (e.g., new addition to the drug library to 
improve compliance)  
5. Compare and associate the aforementioned impact measures and 
their implication on clinical practice or infusion-care delivery.   
Methodology Drug-alert analysis on number, frequency, and pattern over time will 
be performed on selected hospitals. Selection will be based on their 
membership history, activeness in the community, and main user 
profiles. Research will be conducted on the methods related to 
pattern and clustering analysis and association rules in the field of 
data mining, with the most appropriate ones applied in this project. 
Any convergence on system usage and drug-alert patterns due to, 
possibly, community learning behavior is also of interest.   
Potential Impact Well-defined impact measures of the IPI System can demonstrate the 
values created by this specific community of practice and all the tools 
available online. The process of identifying and defining IPI System 
impact can further help us cast other important research questions 
pertinent to the adoption of this novel online system and its 
community. Potentially, we can create an index of system impact 
based on the aforementioned measures for system refinement, 
improvement, and design of similar e-communities of practice in the 
future.   
Project Update Some exploration of the drug-limit library and IPI System users’ usage 
patterns (such as reports generated, charts viewed) was done for one 
IPI System user (specifically, University of Wisconsin Hospital [UWH]) 
prior to starting the analysis on the system impact measures.  This 
exercise greatly familiarized the research staff of the extensiveness of 
a drug-limit library, number and types of changes that can be made 
over time, system-usage patterns, IPI System capabilities, and insights 
into the complexity involved in implementing smart-infusion pumps in 
a hospital setting. 
 We began the analysis of the IPI System impact measures by focusing 
on the Top 10 Drugs history of UWH.  The lists of the Top 10 Drugs per 
quarter (January to March, April to June, etc.), including the ranking 
and number of alerts from 2010 to early 2014, were downloaded and 
compiled for comparison and analysis. For UWH, twenty-six different 
drugs have shown up among the Top 10 over the years. These drugs 
were also examined and ranked by their total number of alerts, 
number of times they were on the Top 10 list, and a weighted index 
combining their ranking order and number of alerts. The different 
ranking methods showed consistent top offenders among the twenty-
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six drugs.  Moreover, significant time and effort were put into 
exploring ways to visualize these drugs and their Top 10 rankings over 
time, and a good option is utilizing a heat map in which drugs and 
time are two axes of a matrix and the color intensity in each cell 
reflects the position in the ranking.  (See Figure 1 below.) 
In addition to analyzing the Top 10 Drugs all together, the ranking 
movement of each of the drugs was teased out. Such ranking 
movement can be plotted in a run chart to analyze any shift, trend, or 
outlier.  The run charts and their 
implication can later be used in 
conjunction with other analyses, 
such as changes made in the drug-
limit library and compliance 
percentage over time (as outlined 
in the research objectives) to 
provide more insight into the 
impact of IPI System adoption. 
Figure 1. (left)  A heat map of the 
Top 10 drugs for University of 
Wisconsin Hospital 
• Top 10 Drug Alerts per 
Device 
The number of alerts per device 
provides a measure (ratio) of how 
many alerts per pump were generated per drug of interest. A heat 
map of the ratios across time for the Top 10 drugs is shown in Figure 2 
below. As the cell colors in the circled area show in the chart of alerts 
per device, overall the number of alerts per device in 2014 has 
decreased from 2010 across the top drugs, and it indicates less alerts 
are happening in the hospital in 
general. 
Figure 2. (left) Drug Alerts per 
Device for UWH 
As these two figures show, top-
ranked alerting drugs only reflect 
relative alerts and cannot indicate 
overall increase or reduction in 
number of alerts. Alerts-per-device 
ratios show trends of the number 
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of alerts per drug. Therefore, putting the figures side by side, the 
ranking heat map and alerts-per-device run chart combined provide a 
better picture of the overall status of alerts over time, as shown in 
Figure 3 below. For example, Propofol stayed as a top alerting drug 
throughout the years, but the alerts-per-device ratio indicates the 
number of alerts has decreased some over the period. 
 Peperacilin/Tazo, on the other hand, has increased in ranking 
among the top alerting drugs, although the number of alerts per 
device did not change much in general.   
 
 
Figure 3. (left) 
UWH Leading Five 




• UWH Vancomycin Alerts in 2013 
The run chart above shows that there is a significant increase in 
Vancomycin alerts during 2013, which led to a more in-depth 
investigation into the medication. We discovered from the data in the 
IPI System that there was a drug-limit library change for Vancomycin 
at the end of March 2013 and the beginning of April, which most likely 
caused the increase in the number of Vancomycin alerts. Its alert 
numbers slowly declined to the prior level after three quarters, which 
may indicate that the 
nursing staff had 





Figure 4. (left) UWH 
Vancomycin Alerts in 
2013 
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• Eskenazi Comparison 
Similar analysis was done for Eskenazi Health.  Their heat maps of the 
top 10 ranked drugs and alerts per device along with the line charts 
are shown in Figure 5 below.  
Figure 5. Eskenazi Leading Five of Top 10 Drug Views, side-by-side 
The trends of these two charts correspond well with one another. 
Since we know that the overall alert numbers were up in 2014, it 
means the average alert rates are stable for these drugs.  
• Cameron Memorial Community Hospital  
Similar analysis was planned for an IPI member hospital of a smaller 
size.  Cameron Memorial Community Hospital is a 25-bed Critical 
Access general community hospital. However, due to its size (and 
patient volume), it appeared that there were not enough alerts data 
to produce plots and draw meaningful conclusions for such a small 
hospital. We need to keep that in mind for future studies (including 
how to study and make fair comparisons of small hospitals).  
Summary 
An in-depth analysis of the drug alerts, their rankings, and alerts-per-
device ratios can be informative of what potential errors could have 
been made but averted while administering drug infusions. However, 
we did realize that since clinical outcomes or other types of clinical or 
administrative data are not currently linked or correlated to the 
available drug-alert data, analysis of the clinical impact of the IPI 
System may not be possible.  
This project concluded as of March 2015. An extension of this work 
has been proposed and the new project will focus on quantifying the 
value provided by employing smart pumps and the IPI System using 
established research results on adverse drug events. We also need to 
explore more about how other types of clinical data (e.g., 
administrative, pharmacy records, etc.) may be combined with IPI 
alerts data to answer some other important and relevant research 
questions.    
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Smart Infusion Pump Alert Threshold Decision Support 
 
Project Team 
Faculty  PI:  Steven J. Landry, Industrial Engineering, Purdue University 
Yuval Bitan, Cognitive Technologies Laboratory, Chicago, IL 
Students TBD graduate assistant (summer, 2015), Industrial Engineering 
Fem Ozcan (undergraduate, spring 2015), Industrial Engineering 
Ryan Widjaja (undergraduate, fall 2014), Industrial Engineering 
Ziya Zhao (undergraduate, spring and fall 2013), Industrial Engineering 
Jeong Joon Boo (undergraduate, spring 2013), Industrial Engineering 
Karen Rockwell (undergraduate, spring 2013), Industrial Engineering 
Adithya Raghavan (graduate, spring 2013), Industrial Engineering 
Nsikak Udo-Imeh (graduate, fall 2012), Industrial Engineering 
Harsh Wardhan Aggarwal (graduate, fall, 2012), Industrial Engineering 
Hyo-sang Yoo (graduate, fall 2011), Industrial Engineering 
Healthcare Partner(s)  All interested IPI members 
Research Direction  
Competencies  Human factors 
Research-to-Impact Phase   Phase B (Research and model development) 
Research Timeline   October 2014–May 2016 
Project Summary 
Healthcare Problem  The current practice to reduce infusion-pump guardrail alerts is to 
review the drug/profile/field-limit combinations that produce the 
most frequent alerts and potentially adjust those thresholds to reduce 
the number of alerts.  This review is limited to approximately the top 
5 most frequent alerts, out of thousands of such combinations, and is 
conducted approximately monthly.  This is insufficient for several 
reasons.  First, a focus on frequencies is misplaced.  The focus should 
be on performance, regardless of frequency.  While true, alerts that 
sound frequently typically have the most number of false alarms, it 
could also be that the alerts need to sound to identify a dangerous 
condition.  Second, these reviews typically focus on alerts that occur 
within individual hospitals, without reviewing across all the hospitals 
in the coalition. 
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Research Objectives  1. To identify the effect of simple decision rules on the number of false 
alarms and missed detections, and 
 2. To improve the practice of alert threshold updating in the IPI guardrail 
library through the development and use of a decision-support tool. 
Methodology An algorithm has been developed to review the infusion-pump 
informatics data to identify all poorly performing alert thresholds.  In 
addition to providing a coded algorithm for re-accomplishing this 
analysis as needed, the list of poor performers will be identified to 
provide guidance on simple changes to all the combinations of 
drug/profile/field limits.  In addition, the algorithm, along with an 
associated tool, can identify the effect, in terms of performance 
(missed detections/false alarms), or altering the guard rail.  This tool 
will be implemented within the IPI tool and subjected to simple 
human–computer interaction testing to improve the interface and to 
allow users to interact with the tool.   
We have also begun collaboration with Dr. Yuval Bitan of HumanEra 
on identifying the mental models of nurses when interacting with the 
infusion pump system. 
Potential Impact The effect will be to (a) reduce alert fatigue by minimizing the number 
of false alarms without increasing important missed detections, and 
(b) to improve library- review practice by providing an intuitive 
interface to help make accurate judgments about a large number of 
thresholds quickly. 
Project Update A prototype algorithm and system have been developed.  The 
algorithm was implemented within a database.  An analysis of the 
impact of a simple rule for setting thresholds was conducted and 
indicated that a simple threshold will reduce the total number of 
alarms, while also reducing missed detections for at least some 
drug/profile/field-limit combinations.  This work was presented in 
poster form at the 2015 International Symposium on Human Factors 
and Ergonomics in Healthcare, as well as at the spring 2015 Infusion 
Pump Informatics Conference. 
I have had numerous teleconferences with Dr. Bitan, and we have 
begun developing the survey that we will use in support of the mental 
model research. 
Lastly, a larger NSF–NIH proposal was developed and submitted as an 
offshoot of this work.  We have not yet heard back on its status. 
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Faculty PI: Ben Dunford, Management, Purdue University 
Students Matthew Perrigino, Management 
Healthcare Partners University of Iowa Health Care, Eskenazi Health, and the University of 
Wisconsin Hospitals and Clinics 
Research Direction 
Competencies Team dynamics 
Research-to-Impact Phase E (Dissemination and evaluation) 
Research Timeline August 2012–December 2015 
Project Summary 
Healthcare Problem While workarounds are a common part of any work environment, 
they can signal larger process issues that need to be addressed. In the 
case of IV pumps, nurses are on the front lines of using the pumps, 
but are rarely involved in the process of developing or installing the 
pumps. Smart-IV pumps should provide additional patient-safety 
benefits; however, if nurses are having difficulties and need to use 
workarounds, these benefits may not be realized. 
 This project seeks to understand attitudes and perceived causes of 
workarounds with smart-IV pumps. As an earlier stage research 
project, the researcher is also seeking to develop and evaluate 
potential new research questions. 
Research Objectives 1. Establish a list of potential causes of workarounds. 
 2. Examine potential methods of perpetuating workarounds through 
the workplace. 
Methodology An anonymous online survey was conducted. Sample size is 
approximately 800 nurses across all three institutions. The survey 
used a variety of question formats, including open-ended, 
dichotomous, and Likert scale.  
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Potential Impact If workaround causes can be identified, changes may be able to be 
made to avoid the need for disruptive workarounds, potentially 
increasing the likelihood that nurses would use the pumps and their 
safety features more. 
Project Update In our pilot study of three US health systems (Eskenazi, U. Iowa, and 
U. Wisconsin), now conditionally accepted for publication in the 
Journal of Patient Safety, we began to explore the causal mechanisms 
behind contagion effects in the usage of smart infusion-pump devices. 
We found strong evidence that contagion effects may be due to how 
nurses are trained and typically solve problems (by going to peers 
rather than administrators or managers for troubleshooting). 
However, given that our pilot study was based on a short anonymous 
survey, the data are limited in the ability to more completely explore 
the existence of contagion effects at various levels of analysis. 
Therefore, we have begun to analyze the IPI data that comes directly 
from the smart pumps themselves to investigate our hypotheses that 
noncompliance with smart-pump safety procedures are heavily 
influenced by social mechanisms. In short, we are looking for evidence 
that workarounds and noncompliance are driven by the culture of an 
organizational unit.     
We examined contagion effects using the “time to override” variable 
in the CatalyzeCare system. Two different approaches were taken. 
First, the binary approach considered any override that was recorded 
as lasting from 0 to 2 seconds as a workaround, while overrides 
ranging from 3 to 20 seconds were not. This approach was taken 
because overriding an alert during the time frame of 0 to 2 seconds 
would not allow enough time for the alert to be processed as a 
conscious thought and to subsequently result in a reasoned or 
informed decision. However, realizing that there could be 
disagreement around this delineation, the second approach treated 
the time to override as a continuous variable ranging from 0 to 20 
seconds. In this sense, we avoided the need to create a cutoff point, 
where lower values of the continuous scale may be considered as 
workarounds and higher values considered as a proxy for problem-
solving behaviors. Results using both approaches were virtually 
identical, so for simplicity, only the results from the second approach 
are discussed below. 
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 To attempt to assess whether response times are an individual-level 
phenomenon or are driven by higher-level influences (e.g., due to 
department- or facility-level influences), we ran multilevel analyses to 
partition out the variance across different levels. In total, there were 
432,517 overrides (all ranging from 0 to 20 seconds) from January 
2013 through March 2014. These overrides were nested in 11,963 
smart pumps, which were nested in 19 different hospital profiles. The 
19 different profiles were nested in 54 different hospital facilities, 
which were nested in 11 hospital systems. Different three-level 
combinations were explored with results from two of these reported 
below. 
 January 2013 February 2013 March 2013 All Periods 
Override .71 .73 .72 .83 
Smart Pump .20 .16 .13 .16 
Facility .08 .10 .15 .00 
  
 The results above treat individual overrides as the level 1 variable, 
smart pumps as the level 2 variable, and facility as the level 3 variable. 
The ICCs indicate that approximately 70% to 80% of the variance in 
response times is attributable to the individual nurse. However, an 
ICC equal to or greater than .05 generally indicates that nesting 
effects cannot be ignored and other influences are beyond individual 
factors. As demonstrated by the table above, variance attributable to 
the smart pump explains on average approximately 16% of the 
variance in workarounds. Finally, for individual months, it also 
appears that variance exists in workarounds at the facility level, as 
well. The results presented in this table may be interpreted the same 
way; the only difference is that “profile” was treated as the level 3 
variable instead of “facility.” These results are consistent with the 
results presented above: although workarounds are driven primarily 
by the individual-nurse level, variance attributable to the specific 
smart pump and the hospital profile also explain significant amounts 
of variance. Based on these preliminary analyses, it appears that there 
may be evidence of a “response time contagion,” where response 
times are due to these higher-level influences.  
 January 2013 February 2013 March 2013 All Periods 
Override .70 .72 .70 .79 
Smart Pump .16 .12 .08 .09 
Profile .14 .16 .22 .12 
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 Our plan is to continue to refine these analyses, accounting for 
possible confounding factors that may be influencing the results.  We 
are working with Aurora Health system in Wisconsin to identify 
possible confounding issues in this analysis.  If we can identify and 
control for potentially confounding influences and get approval from 
enough hospitals for an additional survey distribution, we plan to use 
the IPI data and the analyses we described above in combination with 
a survey administration at multiple health systems to explore how 
shared formalization attitudes at various levels of analysis influence 
contagion effects in how smart pumps are used.  For example, we 
hypothesize that when there is a culture among nurses in 
departments such that smart pumps are considered to be a source of 
unanticipated physical and emotional strain, they are more likely to 
override alerts in less than 2 seconds and contagion effects in 
override-response times are likely to be more prevalent.  In the event 
that we do not get sufficient support for a survey data collection, we 
will conduct a smaller study on contagion effects in noncompliance 
with smart-pump procedures.  
Our plan was to continue to refine the analyses based on the 
collected data and attempt to gather additional survey-based data 
from various healthcare facilities.  
First, multiple papers and presentations have resulted from additional 
analyses of the existing data.  
• One paper was published in the Journal of Patient Safety 
using the pilot-survey data. The article is currently in press. 
This article was primarily descriptive, focusing on the various 
factors (e.g., technological, organizational, and individual) 
contributing to the proliferation of workarounds.  
• We also have presented at the 7th Annual Implementation and 
Dissemination Conference in Washington, D.C. (December 
2014), addressing how specific support translated to 
improved smart-pump reactions, finding that general support 
is a necessary but insufficient requisite for improving nurses’ 
perceptions related to smart-infusion pumps. This paper has 
been conditionally accepted at the peer-reviewed journal 
Health Care Management Review, and is currently undergoing 
revisions.  
• Using the override data from the IPI database, a paper was 
accepted for presentation at the annual Labor and 
Employment Relations Association (LERA) meeting, May 28–
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31, 2015, in Pittsburgh, PA. In receiving a best-paper 
selection, we have been invited to contribute a full-length 
manuscript for publication in the journal, Advances in Labor 
Relations (AILR). 
• Using the survey-based data, two papers, focusing on the 
distinction between how nurses perceive smart pumps to be 
disruptive to themselves and beneficial to patients, have been 
accepted to the Annual Academy of Management meeting, 
August 7–11, 2015, in Vancouver, BC. One paper merited a 
best-paper award and will be published in the Academy of 
Management Conference Proceedings. A third paper with a 
similar focus will be presented at the Infusion Nurses Society 
Conference, May 17–21, 2015, in Louisville, KY. 
Second, in regard to future data collection, multiple connections were 
established at the latest IPI meeting (April 2015 in Iowa City, IA), and 
conversations regarding potential collaboration have been initiated. 
Interested providers include Aurora Health Care, University of 
Nebraska, Cameron Memorial Community Hospital, IU Health, and 
Community Health. Additionally, the previous contacts at Iowa, 
Wisconsin, and Eskenazi Health remain interested in collaborating 
with additional surveys to follow up from the initial data collection. 
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Development of the Infusion Pump Informatics System 
 
Research Team 
Faculty PI:  Ann Christine Catlin, ITaP/Research Computing, Purdue University 




Healthcare Partners Aurora Health 
Cameron Memorial Community Hospital 
Community Health Network  
Deaconess Hospital 
Eskenazi Health 
Franciscan St. Francis Health  
Good Samaritan Hospital Vincennes 
IU Health  
Indianapolis Roudebush VAMC  
 Intermountain Heathcare 
St. Mary’s Hospital  
University of Iowa Health Care 
University of Nebraska Hospital 
University of Wisconsin Hospital 
Research Direction 
Competencies Data visualization 
Databases 
Research-to-Impact Phase Phase E (Dissemination and evaluation) 
Research Timeline April 2013–June 2015 
Project Summary 
Healthcare Problem The alert data collected by infusion pumps can be used to create 
improvements in patient safety; however, the data must be in a 
format that is reliable, timely, and user-friendly. The collection 
capabilities that accompany infusion pumps often provide limited 
data-analysis capabilities, which may not be interactive enough to 
answer more detailed questions. 
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Research Objectives The objectives of this segment include:  
 
1. Integrate the new Carefusion "Knowledge Portal" standard for 
 alert reporting and counting. 
2. Integrate Carefusion "Knowledge Portal" compliance data. 
3. Establish standards for IPI-alert analysis based on IPI community 
 consensus. 
4. Integrate Baxter Sigma Spectrum infusion-pump data. 
5. Upgrade and extend support for Hospira smart-pump alert and 
 compliance data. 
6. Establish terminology standards across smart-pump manu-
 facturers and hospital safety groups when using IPI. 
7. Maintain the IPI infrastructure: database, middleware, data 
 processors, and graphical interface. 
8. Support users. 
 
Potential Impact The analysis enabled through this project helps hospitals identify 
areas for improvement and education in their IV medication-
administration process.  The community of practice that is growing 
through this project provides professional networking and support for 
healthcare providers focused on this issue and helps them 
disseminate important results to their colleagues for even greater 
improvement. 
Project Update Development and support activities continue for the IPI system.  The 
completion of the Baxter integration for alert data and the 
onboarding of Intermountain Healthcare highlights this period. 
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Steve Witz, Regenstrief Center for Healthcare Engineering (RCHE), 
Purdue University 
 
PI:  Rich Zink, RCHE, Purdue University 
Ken Musselman, RCHE, Purdue University 
 
Healthcare Partners Infusion Pump Informatics (IPI) Providers: 
- Aurora Health Care 
- Cameron Memorial Community Hospital 
- Community Health Network 
- Community United Methodist Hospital 
- Deaconess Hospital 
- Eskenazi Health 
- Franciscan St. Francis Health 
- Good Samaritan Hospital Vincennes 
- IU Health 
- Indianapolis Roudebush VAMC 
- Madison, WI VA 
- Metro Health Hospital—Wyoming, MI 
- Parkview Health System  
- St. Mary’s Hospital 
- University of Iowa Health Care 
- University of Nebraska Hospital 
- University of Wisconsin Hospital 
- Witham Hospital 
Physiological Monitor Providers: 
- To be determined. 




Physiological Monitor Vendors: 
- GE Healthcare 
- Philips Healthcare 
- Draeger Medical 
- Covidien 










Competencies Community building 
Research-to-Impact Phase E (Dissemination and evaluation) 
Research Timeline Ongoing 
Project Summary 
Healthcare Problem Alarm hazards were identified as the number 1 hazard for 2014 by 
the ECRI Institute. Alarm fatigue continues to be a problem for 
nurses in the clinical environment.  
 
Research Objectives The evidence-based communities of practice approach provides 
sharing of information between healthcare providers and vendors 
to improve safety, efficacy, and efficiency when using infusion 
pumps and/or physiological monitors. This includes improving 
patient safety, reducing alert fatigue, improving drug-library 
management, and so on. 
Methodology The scientific-collaboration platform, www.CatalyzeCare.org, is 
leveraged as the collaboration space for providers and researchers. 
Providers share information within the community via document 
repositories, containing drug libraries and other documents, and 
threaded discussions allowing clinicians to get information and 
answers from their peers. 
 
RCHE provides the collaboration space, supports the community by 
hosting regular community meetings, and provides technical 
support for using CatalyzeCare. 
Potential Impact Supporting this community of practice provides a dissemination 
vehicle for RCHE research. Additionally, communities of practice are 
being developed nationwide as a method of addressing the need for 
research dissemination. RCHE’s support of and research into 
communities of practice can assist others in establishing successful 
communities. 
Project Update 
 Based on the success of the evidence-based community-of-practice 
model demonstrated by the IPI community, this project is 
expanding to support a new, second group focused on physiological 
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Improving Primary Care Delivery Through 
Allocation of Resources 
 
Research Team 
Faculty PI: W. Bart Collins, Communications, Purdue University 
Brandon Pope, Industrial Engineering, Baylor Health Sciences 
Cleveland Shields, Human Development & Family Sciences, Purdue 
University  
Steve Witz, Regenstrief Center for Healthcare Engineering, Purdue 
University  
Lingsong Zhang, Statistics, Purdue University  
Mike Zentner, ITaP/Research Computing, Purdue University 
Students Ravi Rajesvaran, Statistics and Mathematics 
Healthcare Partners Amy LaHood, MD, MPH, FAAFP, St. Vincent 
Curt Ward, MD, MBA, FAAFP, Program Director, St. Vincent Family 
 Medicine Residency Program  
Maurice Magdi Henein, MD, Clinical Faculty at St. Vincent Family 
 Medicine  
Josh McKinnon, MD, St. Vincent Health 
Jimmy Zimmerman, MD, St. Vincent Health 
Research Direction 
Competencies Patient-centeredness  
Model development 
Research-to-Impact Phase C (Single-site pilot study and evaluation) 
Research Timeline July 2012–.June 2014 
Project Summary 
Healthcare Problem The delivery of high quality patient-centered care (PCC) is essential for 
improving the health of Americans and for containing the costs of 
medical care.  The quality of PCC delivered in a healthcare system is 
difficult to measure, which limits the healthcare system’s ability to 
provide and improve their delivery of PCC.  A critical barrier to 
providing patient-centered care is the potential disconnect between 
patients’ evidence-based needs and personal preferences.  This study 
seeks to improve healthcare by improving the measurement of PCC 
and understanding its enablers and benefits.  
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Research Objectives 1. To identify gaps in patient and physician perceptions of needs, 
wants, and the primary care that is delivered. 
 2. To identify the sources and consequences of these gaps. 
Methodology Retrospective chart reviews will help identify relevant health 
outcomes of the patients in the cohort.  This data on health outcomes 
will serve as initial evidence of the relationship between various 
measures of patient-centeredness and health outcomes.  We have 
identified and are in the process of writing a proposal (using our pilot 
data for support) to fund direct comparison of the most influential 
PCC measures across a range of patient outcomes in the context of a 
large family and internal-medicine clinic with a large residency-
training component. 
Potential Impact This project will contribute to measurement methods for patient-
centeredness by developing a method that accounts for multiple 
dimensions, as well as resource restrictions.  It will impact patients 
when the findings are disseminated in resident-training programs to 
help resident physicians learn about meeting and managing patient 
perceptions and expectations. 
Project Update In phase two of our research, we conducted a secondary chart review 
six months after the survey protocol to determine the extent to which 
patient-centered care was associated with longer-term outcomes, 
including adherence to follow-up visits and health status.  Though our 
N was relatively low in this pilot, and we were measuring outcomes 
six months following a single consultation, patient-centered care was 
associated with some health-status changes, including blood-pressure 
improvements.  PCC delivery was also stronger, based on racial, 
gender, and age similarities with the provider.  Active data collection 
on this project is closed. Results have been presented at two of St. 
Vincent’s annual research conferences, and manuscripts are under 




2015 Board Report Regenstrief Center for Healthcare Engineering
56
Hospital Readmissions (Pilot:  BayCare) 
Research Team 
Faculty Hong Wan, Industrial Engineering, Purdue University 
Brandon Pope, Industrial Engineering, Baylor Medical Center 
Lingsong Zhang, Statistics, Purdue University 
Maribeth Slebodnik, Libraries, Purdue University 
Jose Zayas-Castro, Industrial and Management Systems Engineering, 
University of South Florida 
Peter Fabri, MD, Industrial and Management Systems Engineering,  
University of South Florida 
Laila Cure, Industrial and Manufacturing Engineering, 
Western Michigan University 
 
Staff PI:  Ken Musselman, Regenstrief Center for Healthcare Engineering, Purdue Universit  
Michael Zentner, ITaP/Research Computing, Purdue University 
Peter Baker, Cyber Center, Purdue University 
Jia Xu, Cyber Center, Purdue University 
Zhiyi Tian, Regenstrief Center for Healthcare Engineering, Purdue University 
 
Students Cody Mullen, Regenstrief Center for Healthcare Engineering 
Kalada Kienka, Cyber Center 
Florentino Rico Fontalvo, Industrial and Management Systems Engineering, 
University of South Florida 
Diego Martinez, Industrial and Management Systems Engineering, 
University of South Florida 
Yazhuo Liu, Industrial and Management Systems Engineering, 
University of South Florida 
Ching-Wei Cheng, Statistics 
 
Healthcare Partners BayCare Health System 
 
11 hospitals in and around Tampa, Florida 
 8 general and three specialty hospitals (women’s, children’s and long-term care) 
  - BayCare Alliant Hospital 
  - Mease Countryside Hospital 
  - Mease Dunedin Hospital 
  - Morton Plant Hospital 
  - Morton Plant North Bay Hospital 
  - St. Anthony’s Hospital 
  - South Florida Baptist Hospital 
  - St. Joseph’s Hospital 
  - St. Joseph’s Children’s Hospital 
  - St. Joseph’s Hospital—North 
  - St. Joseph’s Women’s Hospital 
    Bed size range: 108–687 








Research-to-Impact Phase D (Multisite pilot study and evaluation) 
 
Research Timeline I:  April 2010–May 2011 
II:  June 2011–June 2012 
III:  July 2012–August 2012 
IV:  August 2012–June 2013 
V:  July–June 2015 
Project Summary 
Healthcare Problem Existing studies of hospital readmissions typically focus on specific 
diagnoses, age groups, discharge dispositions, payers, or hospitals, 
and often use small samples. It is not clear how predictive models 
generated from such studies generalize across diseases, hospitals, 
or time frames. The goal of this project is to construct a generic 
model of readmission risk, which can be applied to the majority of 
inpatient admissions, and to validate the model’s ability to 
extrapolate across hospital sites and time frames. To better convey 
the nature of the model, a computer application will be built for 
demonstration purposes. 
 
Research Objectives 1. Refine readmissions risk statistical models based on latest 
research findings. 
2. Embellish the Readmission App code to be better aligned 
internally.  
3. Update and examine the fit of the readmission prediction 
model with the latest input factors. 
4. Conduct a comparative analysis of the readmission prediction 
model against another hospital site. 
5. Disseminate the readmission research findings to involve 




• Use logistics regression to predict 30-day readmission rates for 
patients. 
• Construct an optimization model to establish patient-risk classes 
and recommended discharge interventions for each patient 
class based on objective-based intervention characteristics, 
such as efficacy and cost.  
• Build a web-based app for showcasing a Discharge Intervention 
Decision-Support System that can convey effective and 
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appropriate use of prediction and intervention 
recommendation models.  
Potential Impact To help mitigate partnering hospitals’ readmission risks by 
implementing patient-appropriate care transition strategies in 
order to improve the hospital’s quality of care and to have them 
avoid costly penalties. 
Project Update 
 This represents a final update on this project.  The most significant results 
were as follows: 
  Readmission risk predictors 
 









Prior admissions within last 3 months 
Prior admissions within last 3 to 6 
months 
Charlson Comorbidity Index 




Disease Severity Index 
Time on ventilator 
Length of stay 
Discharge disposition 
Behavioral flag substance 
Behavioral flag nonsubstance 
Principal diagnosis (CCS single-level) 
Principal procedure (CCS single-level) 
 
Overall readmission risk-prediction model’s C-statistic:  0.722 
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  The relative importance of each predictor is shown in the graph 
below.  The most important predictors were found to be 
discharge disposition, principal diagnosis, admission type, and 
time since previous discharge (or days since last discharge).  
Looking at it by hospital, these four predictors were found to be 
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  For model longevity, a one-year model was used, and it was found to 
need recalibration after two years, as seen in the plot below.  
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  For all patients who were readmitted within 30 days, the 
table below shows for the top 10% of all discharges by 
diagnosis that 20% return within 3 days and 50% within 
roughly 10 days.  This implies, regardless of the diagnosis, 
an intervention must occur quickly if it is to have significant 
impact.  Seen another way, if one waits 3 weeks (i.e., 21 
days) to intervene, three-quarters of the readmissions that 





Principal Diagnosis  
(CCS Level 2) # ≤ 30 D 20th 50th 75th 
15.1   Liveborn [218.] 2,116 1 8 19 
7.2     Diseases of the heart 6,926 1 8 17 
5.8     Mood disorders 3,597 2 9 18 
8.1      Respiratory infections 1,915 3 10 19 
9.6      Lower gastrointestinal 
disorders 1,898 3 10 18 
10.1   Diseases of the urinary 
system 1,711 3 10 19 
16.2 Fractures 1,277 3 10 19 
7.3      Cerebrovascular disease 1,332 2 9 18 
13.3    Spondylosis; intervertebral 
disc disorders; other back 
problems [205.] 636 3 10 18 
16.10  Complications 1,800 3 9 18 
13.2    Non-traumatic joint 
disorders 550 3 11 19 
5.10    Schizophrenia and other 
psychotic disorders 2,734 3 9 18 
12.1    Skin and subcutaneous 
tissue infections [197.] 819 2 9 18 
17.1    Symptoms; signs; and ill-
defined conditions                                953 3 10 19 
8.2      Chronic obstructive 
pulmonary disease and 
bronchiectasis [127.]          1,425 4 12 21 
10.3    Diseases of female genital 
organs 392 2 7 16 
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  To provide evidence of the ability of predictive readmission 
models to generalize across hospitals, the St. Joseph 
Hospital applied the derived readmission risk-prediction 
model to ten other BayCare hospitals.  This model achieved 
a C-statistic of 0.706 and generalized quite well across the 




BayCare Alliant Hospital 0.722 
Mease Countryside Hospital 0.705 
Mease Dunedin Hospital 0.715 
Morton Plant Hospital 0.704 
Morton Plant North Bay Hospital 0.711 
St. Anthony’s Hospital 0.704 
South Florida Baptist Hospital 0.718 
St. Joseph’s Children’s Hospital 0.703 
St. Joseph’s Hospital—North 0.721 
St. Joseph’s Women’s Hospital 0.707 
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 Below is a histogram and calibration plot of predicted 30-day 
readmissions using the St. Joseph Hospital model as the derivation 
model.  It shows the prediction model is very well calibrated for 
patients with a probability of readmission (within 30 days) less than 
or equal to 0.40 when tested against the ten other BayCare hospitals.  
The model remains well calibrated, although slightly less so, for 
patients with probability between 0.40 and 0.50.  For patients with 
predicted risk above 0.50, the model appears to overpredict.  
However, this is only for a relatively small percentage of the 
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 • The table below addresses cross-time validation for various St. 
Joseph Hospital’s derived readmission risk-prediction models, a 
different model for each of the first five years.  As expected, the 
derivation years (i.e., the first year in a series) outperform the 
validation years.  Yet, while its performance falls off, it remains 









0.696 0.689 0.681 0.681 0.688 
m2 --- 0.750 0.682 0.683 0.688 0.690 
m3 --- --- 0.742 0.689 0.683 0.697 
m4 --- --- --- 0.738 0.682 0.701 




2015 Board Report Regenstrief Center for Healthcare Engineering
65
• Using only BayCare’s independent variable list, the table below shows what 
independent variables (indicated in bold) were significant readmission risk 
predictors at Cleveland Clinic.  The C-statistic for this model of 0.6654, which 
is (as expected) less than the overall model C-statistic of 0.722, but is 
interestingly reasonable.  However, it is significantly lower than the St. 
Joseph Hospital derived model applied to BayCare’s ten other hospitals, 
which ranges from 0.703-0.722. 
 
 









Prior admissions within last 3 months 
Prior admissions within last 3 to 6 
months 
Charlson Comorbidity Index 




Disease Severity Index 
Time on ventilator 
Length of stay 
Discharge disposition 
Behavioral flag substance 
Behavioral flag nonsubstance 
Principal diagnosis (CCS single-level) 
Principal procedure (CCS single-level) 
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Deliverables • A patient stratification analysis was done 
on St. Joseph Hospital patients.  
Somewhat surprisingly, readmission risk 
was not found to be a significant 
stratification factor.  Patients more 
strongly associated (and disassociated) 
with other factors.  However, since the 
interest was in assessing factors for 
readmitted patients, readmission risk was 
forced to be the top-level cut, and the 
patients were subdivided into low, 
medium, and high 30-day readmission 
risks.  The most significant patient 
characteristics (outside of their 
readmission probability) that best 
described these three risk groups differed.  
This result could lead to insights into how 
to better design and apply readmission 
interventions.   
 
1. IIE Transactions on Healthcare Systems 
Engineering Paper (under review):  
“System-wide prediction of general, all-
cause, preventable hospital readmissions” 
2. IIE Transactions on Healthcare Systems 
Engineering Paper (under review):  “A 
literature review of preventable hospital 
readmissions” 
3. Demonstration app 
(http://tinyurl.com/lnwhsgf) comprised of 
a readmission-prediction engine (to 
estimate a patient’s readmission risk 
based on a predetermined set of 
predictors) and an intervention engine (to 
recommend what interventions are most 
appropriate for a given patient given the 
patient’s readmission risk and the cost 
and efficacy of each intervention) 
4. Readmissions app user guide:  “How to 
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All-Cause Unplanned and Preventable Readmissions 
Reduction  
Research Team 
Faculty Lingsong Zhang, Statistics, Purdue University 
Karen S. Yehle, Nursing, Purdue University 
Staff PI:  Ken Musselman, RCHE, Purdue University 
Benjavan Upatising, RCHE, Purdue University 
Kit Klutzke, RCHE, Purdue University 
Rich Zink, RCHE, Purdue University 
Students Donglai Chen, Statistics, Purdue University  
Saiya Sheth, London School of Hygiene and Tropical Medicine 
Healthcare Partner Cleveland Clinic 











Competencies Data mining 
Statistical analysis 
Project management 
Research-to-Impact Phase D (Multisite pilot study and evaluation) 
Research Timeline May 2014–February 2016 
Project Summary  
Healthcare Problem Unplanned and preventable readmissions to hospitals within 30 
days after discharge are driving excessive healthcare cost for 
patients and providers. Reducing unplanned 30-day readmissions is 
an opportunity for many hospitals to improve quality of care and 
reduce the penalty stipulated by the Affordable Care Act.  
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Research Objectives 1. Determine risk-standardized 30-day unplanned readmission rate 
by hospital, hospital-wide, and by selected specialty cohort.  
2. Develop a 30-day unplanned readmission prediction model for 
the nine Cleveland Clinic hospitals in NE Ohio.  
3. Analyze time from discharge to next admission to identify where 
there are high readmission rates and patients that stay out of 
the hospital long enough for the healthcare provider to do 
something about it in an outpatient setting.  
4. Stratify patient population to surface meaningful patient 
characteristics across various readmission risk sectors.  
 
 
Methodology The statistical models and other analyses will be based on prior 
1 to 3 year’s admissions data. Multilevel logistic regression will 
be used for Objectives 1 and 2.  For objective 4, data mining will 
be used to segment the patient population. 
 
Potential Impact Improve quality of patient care to reduce unnecessary 30-day 
readmissions, healthcare utilizations, and cost of care. 
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Project Update The previous readmission study done for BayCare laid the 
foundation for exploring readmissions at Cleveland Clinic.  The latest 
findings for Cleveland Clinic are given below. 
 
• Readmission risk predictors 
 
Category Independent Variables 
Demographics Marital status 
Payer class 
Historical Utilization Prior admissions within last 3 months 
Prior ED visits within last 6 months 
Charlson Comorbidity Index 
Days since last discharge 
Current Utilization Admitting hospital 
Length of stay 
Discharge disposition 
Discharge date’s season 
Behavioral flag nonsubstance 
Days to next outpatient visit 
 
• Overall readmission risk-prediction model’s C-statistics: 
- Logistic Regression: 0.7540 
- Multilevel Logistic Regression: 0.7750 
 
• For all adult patients who were readmitted within 30 days: 
- 25% were readmitted within 1 week of discharge 
- 75% were readmitted within 3 weeks of discharge 
 
• Patients discharged to a skilled nursing facility tend to be 
readmitted sooner than those discharged to home or home 
care, except for patients diagnosed with Anemia. 
 
• As with the BayCare system, the number of days to a patient’s 
next readmission did not appear to depend on his or her CCS 
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Population Health Management Modeling to Support 
Accountable Care Delivery (Pilot: OurHealth) 
 
Research Team 
Faculty Steve Witz, Regenstrief Center for Healthcare Engineering, Purdue 
University 
Staff PI:  Ken Musselman, RCHE, Purdue University 
Ping Huang, RCHE, Purdue University 
Kit Klutzke, RCHE, Purdue University 
Students Hambisa Keno, Industrial Engineering 
Healthcare Partner OurHealth 
Research Direction 
Competencies Data analysis 
Modeling 
Stratification 
Interactive data exploration 
Cluster analysis 
Research-to-Impact Phase C (Single-site pilot study and evaluation) 
Research Timeline March 2014–December 2015 
Project Summary  
Healthcare Problem RCHE is collaborating with OurHealth to develop a decision-support 
capability to improve the health of company communities to improve 
their quality of care and cost-effectiveness. This research seeks to 
support this overall initiative by performing clinical analytics to 
identify medical-management strategies that will improve population 
health in targeted areas through the use of a medical-management 
decision-support tool. The process will leverage OurHealth’s clinical 
knowledge with claims and biometric information coming from 
OurHealth’s patient population to identify those patients whose 
outcomes will benefit the most from intervention efforts and better 
informed choices. 
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Research Objectives 1. Evaluate data availability and technology opportunities associated 
with OurHealth functioning as an information source for the 
operation of the Population Health Model. 
 2. Verify the Data Input Processor accurately captures insurer input. 
 3.  Establish appropriate health metrics to support the stratification 
of OurHealth’s patient population. 
 4.  Investigate various approaches to patient-risk stratification that 
will improve OurHealth’s ability to identify and prioritize sound, 
evidence-based medical-management strategies. 
 5.  Evaluate the model’s effectiveness in providing actionable steps 
for providers to pursue better accountable-care delivery. 
 6.  Disseminate the research findings to OurHealth and other 
appropriate organizations. 
Methodology Upload and verify the transfer of the data elements from the 
OurHealth system to drive decision-support methodologies, filtering 
the elements as appropriate. Parameterize the models to best 
address the environment, and then work with OurHealth to 
understand the appropriateness and usefulness of the models in 
determining targeted medical-management strategies for this 
population. 
Potential Impact To improve accountable-care delivery effectiveness through the 
improved selection and adoption of clinic-specific management. 
Project Update Did a comparative analysis (using OurHealth’s biometric data) of three 
methodologies:  score, appraise, and compare.  The table on the next 
page provides a summary of the findings.  The compare method 
showed a number of significant advantages, including ability to scale 
(number of criteria), addressing missing data, displaying more 
discrimination power, and not requiring consensus-building.   




The research team is now working with OurHealth to advance three 
initiatives:  
1. Combine claims data with biometric data to assess OurHealth’s 
patient population across a wider array of health factors. 
2. Explore various means of extracting patient outliers. 
3. Examine the ability of the compare methodology to go beyond 
relative comparisons to absolute.  
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Population-Health Management Modeling to Support 
Accountable-Care Delivery (Pilot:  St. Vincent Health) 
 
Research Team 
Faculty PI:  Steve Witz, Regenstrief Center for Healthcare Engineering, Purdue 
University 
Nan Kong, Biomedical Engineering, Purdue University 
Staff Kit Klutzke, RCHE, Purdue University 
Students Mina Ostavari, Industrial Engineering 
Healthcare Partners St. Vincent Health 
Research Direction 
Competencies Data analysis 
Modeling 
 
Research-to-Impact Phase C (Single-site pilot study and evaluation) 
Research Timeline March 2014–December 2015 
Project Summary  
Healthcare Problem RCHE is collaborating with St. Vincent Health to improve the quality of 
care and cost-effectiveness for populations. This research defines 
populations as individuals who are eligible to receive health benefits 
through their employer’s health-benefits plan.  The participating 
employers have self-funded health-benefits plans and have 
established contracts for work-site clinics and consultation for 
population-health management.  This research analyzes patterns of 
healthcare utilization, as represented by healthcare claims data, and 
identifies medical-management strategies that will improve 
population health. The research will monitor the implementation of 
selected medical-management strategies and use  patient outcomes 
and the employer’s paid claims as metrics for population-health 
management effectiveness.  
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Research Objectives This research will: 
• Develop a longitudinal claims data base and supportive 
information to identify population-health conditions and 
healthcare utilization. 
• Identify population-health management opportunities to 
improve healthcare quality and cost. 
• Evaluate the effectiveness of population-health management 
strategies. 
• Disseminate findings for generalization when appropriate to 
other populations to enhance population-health management 
knowledge and practices. 
 
Methodology Statistical analyses 
Potential Impact To improve population-health management that improves quality and 
cost through evidence-based collaborations among employers and 
providers.  
Project Update A claims data base has been constructed and is being analyzed.  The 
patterns of utilization by members of the population have been 
assessed to provide detailed analyses of utilization by population 
members characterized by demographic and condition variables. 
RCHE and St. Vincent clinicans are grouping population-health 
managment strategies in categories of services to be delivered at 
work-site clinics, the larger integrated delivery system at St. Vincent 
Health, and strategies to reduce the costs of high volume services to 
the employer. 
Employers are starting the process of reviewing population-health 
management plans.  This review will identify the first series of 
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Affecting Cancer Together  
 
Research Team 
Faculty PI:  Cleveland Shields, Human Development and Family Studies; 
Purdue University  
Healthcare Partner Community Cancer Health Advocacy Groups in Indiana and Lay 
Educators 
Research Direction  
Competencies Community-centered research 
Statistical analyses 
Lay community involvement in education and prevention 
Research-to-Impact Phase Phase D (Multisite pilot study and evaluation) 
Research Timeline January 2011–January 2015 
Project Summary 
Healthcare Problem The reduction in cancer morbidity and mortality is dependent upon 
effective public programs for cancer awareness, prevention, and 
screening.  Limited public knowledge and ineffective messaging, 
particularly for underserved communities, have led to disparities in 
cancer incident rates among certain population groups. 
Research Objectives 1. Prevention of cancer and other chronic diseases in Indiana through 
awareness and education, providing a bridge to health resources and 
services, as well as developing health leaders, lay health educators, 
and health motivators in the community.  
 2. Improve health outcomes for all, including underserved 
populations. 
Methodology Nontraditional healthcare settings in the community are utilized to 
promote awareness, educate about, motivate, and encourage 
prevention and early detection of cancer and chronic diseases. The 
focus is on integrating the community’s input and feedback into 
ACTion. 
Potential Impact The evaluation project has been completed.  We interviewed 55 
barbers and 165 barbershop clients.  We found that the more highly 
educated barbers and married barbers carried on more conversations 
about health and cancer prevention than did less educated unmarried 
barbers.  Their clientele also were less knowledgeable.   
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 We have two publications under review, one has received a revise and 
resubmit.   
 Hill, B. C., Black, D. R., & Shields, C. G. (under review). 
Barbershop prostate cancer education: Factors associated 
with client knowledge. American Journal of Men’s Health. 
 
 Hill, B. C., Black, D. R., & Shields, C. G. (under 
review). Barbershops in a black community: Frequency of 
prostate cancer discussion. Ethnicity & Disease.  
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See-What-I-Do:  Increasing Mentor and Trainee Sense of 
Co-Presence in Trauma Surgeries with the STAR Platform 
 
Research Team 
Faculty PI:  Juan Wachs, Industrial Engineering, Purdue University 
Voicu Popescu, Computer Science, Purdue University 
Brian Mullis, MD, Surgery, Indiana University School of Medicine 
Gerry Gomez, MD, Surgery, Indiana University School of Medicine  
Sherri Marley, Indiana University School of Nursing  
Students Dan Anderssen, Industrial Engineering, Purdue University 
Sthitapragyan Parida, Electrical and Computer Engineering, Purdue 
University 
Healthcare Partners Eskenazi Health 
Fairbanks Hall Simulation Center 
Large Animal Research Center 
Research Direction 




Research-to-Impact Phase D (Multisite pilot study and evaluation) 
Research Timeline 2014–2016 
Project Summary 
Healthcare Problem Optimal trauma treatment integrates different surgical skills that are 
not always available in military field hospitals.  Telementoring can 
provide missing expertise; yet, current systems require the trainee to 
frequently focus on a nearby telestrator, fail to illustrate the next 
surgical steps, and give the mentor an incomplete picture of the 
ongoing surgery. 
 The development of the System for Telementoring with Augmented 
Reality (STAR) will address these shortcomings. 
Research Objectives 1. Develop and assess a transparent-display augmented reality 
system that enhances trainee’s natural view of the surgical field 
by illustrating current and next surgical steps. 
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2. Develop and assess a patient-size interaction platform where the 
mentor uses gestures to mark, annotate, and zoom in on 
anatomic regions over a projected image. 
3. Validate and refine STAR with corpsmen in cricothyroidotomy 
procedures on a human–patient simulator.  
4. Validate the refined STAR with surgery residents in hemorrhage-
control procedures within a damage-control laparotomy on live 
porcine models in a simulated austere environment. 
 
Methodology Methodologies used for each of the corresponding objectives above 
are given below: 
 3-D scene acquisition, camera calibration, color-to-depth registration, 
head tracking, 3-D rendering, parameterized simulation, and 
visualization of simulation data. 
 Hidden Markov Models, Kinect-based tracking library, and Wizard of 
Oz prototyping. 
 Trauma Man Cric simulator and direct corpsmen and/or paramedics 
to perform a surgical cric, using direct observation and video review 
to evaluate with the Prehospital Trauma Life Support (PHTLS) 
competency checklist. 
 Hemorrhage-source identification and control through direct 
observation and video review evaluated by trauma surgical faculty of 
a Level 1 trauma center. 
Potential Impact STAR will increase access to subspecialty surgical expertise, help 
refresh skills of surgeons returning from temporary deployment, and 
decrease complications rates for recent medical-school graduates in 
deployment. 
Project Update Preliminary indications are that STAR allows trainees to follow some 
mentor instructions more accurately.  The main finding is that focus 
shifts were greatly reduced when using STAR, as opposed to the 
conventional system.  This is a reasonable result, given that a 
participant in the conventional condition is required to shift focus to 
access the instruction, while in the STAR condition, accessing the 
instruction does not require shifting focus.  Based on the completion 
of the initial experiment, we can state that, on average, the 
placement error was considerably smaller when using the augmented 
reality system than when using a separate screen.  The tablet provides 
precise feedback as to where a pointer should be placed and the 
participant leverages this feedback to minimize placement error.  
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Improving Medication Adherence through Practitioner 
and Patient Health Literacy Education 
 
Research Team 
Faculty Kim Plake, Pharmacy, Purdue University 
Healthcare Partner Wishard Health Services 
Research Direction 
Competencies Health literacy assessment 
Health literacy intervention 
Research-to-Impact Phase Phase C (Single-site pilot study and evaluation) 
Research Timeline June 2011–December 2015 
Project Summary 
Healthcare Problem Treatment adherence after cardiovascular events has been cited as 
being as low as 54 percent after one year. Functional health literacy 
has been shown in a number of studies to affect a patient’s 
medication adherence. Prior to an Institute of Medicine report in 
2004, little health literacy education was provided in professional 
schools, leaving many nurses and pharmacists ill-equipped to work 
with low health literacy populations. 
Research Objectives This project seeks to develop and implement a health literacy 
education program to assist providers in working with patients of 
varying levels of health literacy. The program will also enable 
clinicians to develop their own patient education approaches and 
tools. Long term, the program objectives are to: 
1.  Integrate health literacy tools into contemporary practice; 
2.  Improve adherence to antihypertensives and cholesterol-lowering 
      medications; and 
3.  Improve clinical outcomes in patients with low health literacy. 
Methodology A comprehensive list of gaps and unmet needs was established 
through a review of the literature and in consultation with various 
practitioners. An in-person session will be developed with material to 
address these gaps. A website will also be developed to serve as an 
additional resource after the presentations. 
2015 Board Report Regenstrief Center for Healthcare Engineering
80
 The program will be assessed using a decision-oriented logic model 
type developed by the Kellogg Foundation and recommended for 
complex program designs.  
Potential Impact Patients who are more health literate are more able to understand 
their condition, participate in managing it, and adhere to their 
treatment regimen, thereby improving their health. 
Project Update This project was jointly funded by the Regenstrief Center for 
Healthcare Engineering and Pfizer. It builds on the faculty members’ 
existing expertise in patient health literacy and health literacy 
education developed through several previous projects. RCHE 
provided seed funding for one such project and others have been 
externally funded. 
 Project funds enabled the purchase an automated refill reminder 
system. This system calls patients to remind them to get their 
prescriptions refilled. It is automated and allows the patient to choose 
to refill their prescription when on the call. 
 There were multiple delays with this project due to delays in 
implementing the refill reminder system, as well as limited 
engagement from the providers in the educational sessions.  The 
analysis of proportion of days covered is continuing as it was a 
longitudinal study.  The baseline Proportion of Days Covered (PDC) 
has been calculated and the 3 month data point will be analyzed 
next.  We have 6 and 12 month data points as well.  The primary 
evaluation will be evaluating the refill reminder system.  
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Comparative Effectiveness of Different Implementations 




Faculty PI:  Cleveland Shields, Human Development and Family Studies, 
Purdue University 
Elliot Friedman, Human Development and Family Studies, Purdue 
University 
Stewart Chang Alexander, Consumer Science, Purdue University 
Staff Poching DeLaurentis, Regenstrief Center for Healthcare Engineering, 
Purdue University 
Students Phanlada Chatha-Hill, Health and Kinesiology 
Lindsay Fuzzell, Human Development and Family Studies 
Healthcare Partner Indiana Rural Health Association (IRHA) 
Research Direction  
Competencies Comparative effectiveness 
Quasi-experimental design 
Research-to-Impact Phase Phase B (Research and model development) 
Research Timeline May 2015–December  2015 
Project Summary 
Healthcare Problem This project supports the community work required to prepare a 
Patient Centered Outcomes Research Institute (PCORI) application.  
PCORI applications and contracts are different from NIH and NSF 
applications in that they require extensive involvement of the 
community in which the research is planned. 
 
In this case, community partners include patients, physicians, and 
other providers, administrators, and IRHA staff.  We will need to 
engage these stakeholders in meaningful conversations that broaden 
our understanding of rural health concerns, help us develop 
appropriate outcome and process measures, and help us adapt the 
Patient Centered Medical Home (PCMH) model appropriately in the 
rural study sites. 
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Research Objectives 1.  Conduct a comparative effectivenss study using a quasi-
experimental design comparing different models of PCMH in rural 
IRHA sites. 
 2.  Work with stakeholders to identify sites and define PCMH models 
for them.  Examine whether and how to include suburban or urban 
sites for comparison. 
Methodology PCORI methodology standards require us to develop interventions, 
outcomes, processes, and all research plans in collaboration with 
community partners.  The work is focused on comparative-
effectiveness research in which two or more treatments with known 
efficacy are compared.  The idea is not only to find out what works 
best but also under what circumstances and with whom (i.e., to 
examine the heterogeneity of treatment effects).   
Potential Impact IRHA consists of 30 hospitals and has a presence in virtually every 
rural county in Indiana.  Writing and submitting this PCORI application 
represents a unique opportunity for RCHE and for Health and Human 
Sciences at Purdue to develop working relationships with rural 
healthcare systems.  As a land-grant university with a mission to serve 
the needs of the whole state, we hope to build lasting partnerships 
between RCHE and IRHA. 
Project Update This project has just now been initiated. 
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Faculty PI:  Bart Collins, Communication, Purdue University 
  
Students Heather Fedesco, Communication, Purdue University 
Wan Jiang, Science, Purdue University 
Yao Tang, Statistics, Purdue University 
 










Prediction and Forecasting 
Risk Stratification 
 
Research-to-Impact Phase A (Healthcare system evaluation with stakeholder input) 
 




Research Objectives The primary objective of this project is to identify outcomes associated 
with employee health coaching initiatives on a variety of potential 
outcomes, including health claims, health-risk status, and preventative 
health utilization. Secondary objectives include examination of 
demographic, psychosocial, and health factors associated with 
variation in the effectiveness of coaching.  
 
Methodology Two primary data sets and methodologies are being implemented to 
reach these objectives. First, an analysis of an existing de-identified 
data set of longitudinal health claims and risk information (MEDai-
based) associated with a variety of regional employers is being 
analyzed to evaluate outcomes of approximately 500 wellness coached 
employees with a propensity scored matched set of uncoached 
employees. Second, coached individuals are participating in an online 
survey to evaluate additional psychosocial and self-reported outcomes 
associated with coaching participation. The survey focuses on 
wellness-coaching communication characteristics and their impact on 
employee-health self-management processes.  
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Potential Impact Employers are increasingly investing in wellness and prevention-
oriented initiatives. However, short- and long-term impact of such 
interventions needs investigation. Additionally, this project should help 
profile employee characteristics that respond best to this type of 




Project Update IRB approval for project was granted in November 2014. De-identified 
MEDai data was received in December 2014, representing 40 months 
of MEDai health-claim summaries and risk information for 
approximately 20,000 covered lives. Approximately 500 individuals 
received wellness-coaching interventions during that time period. 
Propensity score matched individuals were compared with the 
wellness-treatment group. Results of the analysis identified that 
wellness-coached individuals were more engaged with formal 
healthcare-delivery services than similar uncoached individuals. 
Analyses suggest that this increase in utilization was best explained by 
increased engagement with preventative health services and was 
relatively consistent across individuals addressing a wide range of 
health and wellness issues.  Survey data from the coached population 
was collected in April, and results of this component are currently 
being analyzed. This analysis of the secondary data sets formed the 
basis of Heather Fedesco’s successfully defended dissertation in May 
from the Brian Lamb School of Communication, entitled: “Employee 
wellness coaching as an interpersonal communication intervention: 














Faculty PI:  Steve Witz, Regenstrief Center for Healthcare Engineering, Purdue 
University  
Rebecca Doerge, Statistics, Purdue University  
 
Staff Zhiyi Tian, Regenstrief Center for Healthcare Engineering, Purdue 
University 
  
Student Simeng Qu, Statistics, Purdue University 
 











Research-to-Impact Phase B (Research and model development) 
 





Healthcare Problem Fee-for-service healthcare reimbursement is alleged to provide financial 
incentives for healthcare providers to deliver redundant and/or 
unnecessary patient services.  New forms of reimbursement collectively 
referred to as value-based purchasing seek to change these inherent 
financial incentives by prospectively limiting the amount of 
reimbursement to providers.  These policies shift financial risk from 
third-party payors to healthcare providers and are intended to 
simultaneously improve patient outcomes and cost-effectiveness. 
 
Healthcare providers have not developed actuarial methodologies to 
assess and mitigate the new financial risks imposed by value-based 
purchasing.  Providers’ reluctance to accept risk without these 
management capabilities deters the ability to assess the purported 
merits of value-based purchasing. 
 
One form of value-based purchasing is bundled payment 
reimbursement.  Bundled payments combine all services for a defined 
episode of care into a single amount of payment.  Providers may place 
bids for bundled payment services to gain market share.  Providers are 
financially at risk for the patient care provided under these contractual 
awards.   




Research Objectives Develop and validate analytic methodologies to assist healthcare 
providers to assess and mitigate financial risk inherent in bundled 
payment.  
 
• Decompose the financial variance among episodes of care for a 
given case type into component elements. 
• Support providers’ review and re-engineering of the care delivery 
process to reduce the variation in elements of care, while 
improving quality and cost management in the care episode. 
• Provide quantitative methodologies to establish bid prices for 
care episodes in bundled payment contracting. 
 
Methodology Use point estimate to estimate the mean and variance of the cost of a 
care episode.  Total knee arthroplasty (TKA) will be the initial care 
episode analyzed.  Episode costs will be decomposed into three 
components: 30 days before hospitalization, the index hospital 
admission, and 90 days post-acute care.  The contribution of each of 
the three components to the total episode variance will be 
determined.  Within each component, identify the chargeable items 
that contribute to total variance.  
 
Replicate this analytic approach on hip arthroplasty episodes to 
determine the feasibility of this approach on episodes other than TKA. 
 
Provide analyses of financial risk and options to mitigate risk to 
healthcare providers to support their determination of care-delivery 
profiles, associated financial risk, and contracting terms to establish 
episode bids. 
 
Potential Impact Help to reduce healthcare cost, while improving quality of care.  
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Project Update Considering the impact and potential for quality and efficiency 
improvement, total knee replacement (TKA) is chosen for initial 
condition to study for bundle payment. Three years of medical-claim 
data has been received from Cooperative Managed Care Services 
(CMCS) for patients with St. Vincent Health Care Management 
Organization (CMO) health plan.  
 
Index TKA procedures have been identified by a series of CPT codes, 
ICD9 procedure codes, and DRG codes. In the three-year period, 31 
patients had at least one total knee replacement procedure, and three 
of them had two procedures, which resulted in 34 index procedures in 
total. Each of the index procedures triggered an episode and was 
counted as an independent episode for analysis. From the 34 episodes, 
22 patients were females and 12 patients were males. Patient age at 
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 We define an episode as an index procedure, including 30 days prior and 
90 days post. Currently, we evaluate the total charge during the entire 
episode. The total charge is the sum of four components: Service Paid 
Amount, Copay Amount, Deductible Amount and Coinsurance Amount. 
The total charge varies dramatically from episode to episode, and ranges 











To find the source of variation, we study the association between total 
charge and various factors, such as patient age, patient gender, hospital 
length of stay (LOS) for total knee replacement, hospital discharge 
disposition, and patient Charlson Comorbidity score. Among those 
factors evaluated, we find that longer length of stay is statistically 
significant with higher total charge.    
 
 
LOS for TKA N 
Total Charge 
Mean Std Dev 
1 1 30785.7400 . 
2 8 21893.9638 7586.7430 
3 17 30400.5941 5708.7431 
4 6 33303.2133 14721.4012 
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The analyses for TKAs continued with a review and editing of patient 
outliers.  Eight patients with TKAs were eliminated from the analyses 
due to atypical care.  The elimination of these patients from the 
analyses did not significantly change the mean-episode charges.  It 
did, however, reduce variation in total episode charges as indicated 
by a reduction in the coefficient of variation from .382 to .251. 
Total episode cost was divided into components of the episode:  
preadmission, admission and postadmission.  Mean total charges for 
preadmission represented 4% and postadmission was 18% of the total 
average episode charges.  The admission component represented 
78% and included hospital charges at 64% and professional charges at 
14% of the average total episode charge.  The hospital charges for the 
admission component and the posthospitalization charges 
represented the largest variance in charges.  These two components 
of care have been selected for further analyses, and data collection to 
enable this expanded analyses is underway. 
RCHE is also replicating the analyses of TKA episodes with a sample of 
patients who received a total hip replacement.  The intent is to test 
the generalizability of findings in a second cohort of patients.  As 
anticipated, the mean charges for hip replacement differ significantly 
from the TKA episode charges.  We have found similar findings with 
regard to the effect of editing patients who received atypical care on  
significantly reducing variance in the total episode charge and the 
relative percent of total episode charges generated during the 
preadmission, admission and postadmission components.  Two hip 
patients were found to have postdischarge charges that were 
significantly higher than other patients in their cohort.  Both of these 
patients required rehospitalization for hip revisions, which indicates 
an opportunity to study these patients further for opportunities to 
reduce the need for revision procedures. 
This bundled-payment analysis will include a review of the data with 
the hospital and orthopedic surgeons to evaluate research findings 
and additional research directions. 
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Development of Physiological Monitor Databases 
Research Team 
  
Faculty Elisa Bertino, Computer Science, Purdue University 
 
Staff PI:  Md Munirul Haque, Regenstrief Center for Healthcare 
Engineering, Purdue University  
Rich Zink, Regenstrief Center for Healthcare Engineering 
Peter Baker, CyberCenter, Purdue University 
Healthcare Partners Monitor Manufacturers: 
• GE Healthcare 
• Philips Healthcare 
• Draeger Medical 
• Covidien 
• Spacelabs Healthcare 
 
Healthcare Providers: 
• To be determined 
 
Dissemination Partner: 





Big data analytics 
Research-to-Impact Phase A (Healthcare system evaluation with stakeholder input) 
Research Timeline November 2014–June 2016 
Project Summary  
Healthcare Problem The Emergency Care Research Institute (ECRI) identified alarm 
hazards as the number-one hazard for 2014. Alarm fatigue 
continues to be a problem for nurses in the clinical environment, 
but unfortunately there is no database of physiological parameter 
alarm records. As a result, hospitals are failing to take any 
meaningful measure to reduce the number of alarms being 
generated by different monitor devices. Finally, the parameters 
monitored by these devices are not stored in a continuous 
fashion. The longitudinal historical records of these parameter 
values can provide a novel analytical domain for researchers and 
vendors. 
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Research Objectives 1. Document agreed-upon terms for physiological parameters.  
2. Document default values, soft limits, and hard limits (where 
applicable) of physiological parameters categorized by 
different vendors.  
3. Document default values, soft limits, and hard limits (where 
applicable) of physiological parameters categorized by 
different profiles and hospitals.  
4. Design and develop a database for physiological-parameter 
alarms.  
5. Develop the analytical and visualization tool based on the 
collected alarms.  
6. Finally, start building a 24/7 database based on selected 
physiological parameters. 
7. Establish an evidence-based community of practice. 
Methodology We will be working with the Association for Advancement of 
Medical Instrumentation (AAMI), vendors, hospitals, and other 
teams to achieve objectives 1 through 4. The Regenstrief Center 
for Healthcare Engineering (RCHE) at Purdue will develop the 
Physiological Parameter Informatics (PPI) System (Objective 4 and 
5) to make it easy to analyze physiological-parameter alarm data 
and best practices. The tool allows for physiological-parameter 
alarm data to be readily accessible, meaningful, and actionable. 
The participating hospitals form a virtual community that 
exchanges information, shares analysis results, and collaborates on 
ways to improve the tool and patient safety. The scientific 
collaboration platform, www.CatalyzeCare.org, is leveraged as the 
collaboration space for providers and researchers. RCHE provides 
the collaboration space, supports the community by hosting 
regular community meetings, and provides technical support for 
using CatalyzeCare. The web-based application for analyzing 
physiological-parameter alarm data will be deployed in 
CatalyzeCare. 
Potential Impact Improve safety, efficacy, and efficiency in managing physiological 
monitor alarm data. This also includes reducing alert fatigue. The 
analysis enabled through this project helps hospitals identify areas 
for improvement and education in their physiological monitor 
alarm-management process. The community of practice that will 
be growing through this project will provide professional 
networking and support for healthcare providers focused on this 
issue, and help them disseminate important results to their 
colleagues for even greater improvement. The analysis of a 24/7 
physiological monitor parameter database may lead to more 
customized, patient-based alarm management. 
Project Update A high-level project plan has been developed identifying three 
systems to be developed. Phase 1 is the creation of a system to 
store and analyze vendor and provider default settings. Phase 2 is 
the creation of a system to store and analyze monitor alarms, and 
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Phase 3 is the creation of a system to store and analyze continuous 
monitor data.  Initial data for vendor and provider defaults have 
been captured and will be used in the development of the initial 
Phase 1 system.  Programming on the system is expected to begin 
in May 2015.  For Phases 2 and 3, AAMI is coordinating additional 
meetings with monitor vendors to understand what alarm and 
continuous data is available as inputs to the systems.  The vendor 
meetings are planned for completion by June 1, 2015.  Following 
the vendor meetings, AAMI will coordinate meetings with 
providers to better understand the issues they face and their 
analytic needs in this space.  A student researcher has been 
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Transitions in Care Pilot: Evaluate the Impact of  









Co-PI:  W. Bart Collins, Communication, Purdue University 
Co-PI:  Steve Witz, Regenstrief Center for Healthcare Engineering, 
Purdue University 
Yuehwern Yih, Industrial Engineering, Purdue University  
 
Shan Xie, Industrial Engineering  
India Bergeland, DURI Scholar, Industrial Engineering  
Brad Harris, Industrial Engineering 
Lindsey DiTirro, Communication 
Ryan Cummings, Communication 
 
Healthcare Partner Michiana Health Information Network (MHIN) 
Research Direction 
  
Competencies Health IT evaluation  
Workflow analysis  
Statistical analysis 
 
Research-to-Impact Phase B (Research and model development) 




This research was initiated to address difficulties in patient-care 
transitions identified in our study of critical-access hospitals, reported 
in the literature, and by the Office of the National Coordinator for 
Health Information (ONCHIT).  A common issue in the quality of 
transitions of care is adequacy of communications pertaining to 
patients’ conditions and care plan.  This research is divided into a 
systems analysis of transitions of care communication, and the 
perceptions of care providers relative to using direct messaging. 
 
 
Healthcare Problem Effective patient transitions require communication among healthcare 
providers pertaining to the patient’s condition and treatment plan. The 
hospital-discharge summary and referral request are common 
communication formats for the exchange of this information. 
Previously reported research documents indicated that these types of 
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communication may not occur in a timely manner or may be missing 
critical information. These communication limitations are associated 
with ineffective care transitions and care coordination. 
Research Objectives 1. Assess the value of electronic communications at improving 
patients’ continuity of care during care transitions.  
2. Identify opportunities to use electronic communications most 
effectively within current provider communication processes.  
3. Improve care-communication timeliness and content required 
for patient continuity of care. 
 
Methodology The analyses are organized in four sections. First, de-identified patient 
data are analyzed to identify the number and types of care transitions 
within a 30-day posthospital discharge. Second, semistructured 
interviews are conducted with hospitals and skilled nursing facilities 
(SNFs) to collect data to evaluate the information transfer process pre- 
and postimplementation of electronic communications in terms of 
content, format, timeliness, cost, and security. Time-stamp data are 
analyzed to evaluate the usage of the system and identify potential 
system breakdown and bottleneck. Third, patient outcomes, such as 
readmission, ED visit, length of stay, etc., are analyzed to evaluate the 
impact of the interventions. Fourth, provider attitudes and 
perceptions of direct-messaging care transitions, and meaningful use 
will be measured through survey methods in collaboration with MHIN. 
 
Potential Impact The improved communication made possible through this project is 
expected to result in: 
1. Increased provider satisfaction with the availability and quality 
of clinical information.  
2. Improved patient outcomes (e.g., a reduction of hospital 
readmissions among patients discharged to a SNF or LTPAC 
facility). 
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Project Update IRB approvals have been granted for existing data, interview, and 
survey. Data collection for survey began May 2015. Ten interviews 
were conducted with hospitals and skilled nursing facilities. The 
referral process pre- and postimplementation of electronic 
communications was assessed. The workflow analysis was categorized 
into SNFs that have clinical liaison and those that do not have clinical 
liaison. The results for the first category are included here. The 
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For major tasks performed by a social worker assistant and clinical 
liaisons, the time that it takes to finish each step was estimated based 
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The benefits of having electronic communications are summarized as follows: 
 
1. Saves time for hospital staff (e.g., printing time, faxing time, and 
searching for a fax machine) and clinical liaisons from SNFs. 
2. Information is readily accessible. Clinical liaisons are less dependent 
on social workers and their assistants. 
3. Social worker can spend more time with patients without being 
interrupted by others who seek more information. 
4. Information is available to multiple people at the facility. 
5. Eco friendly—less paper printing 
6. More secure than fax by reducing the possibilities of the wrong 
person picking up the fax, loss of information, and potential breach of 
patient-information privacy. 
In addition to the benefits, the following potential improvements to the 
current system would make the electronic communications more effective. 
1. Incorporate patient name to the subject line of direct messaging. 
2. Integrate face sheet and 72-hour report to the electronic referral 
template or save them as electronic documents that could be attached 
to direct messaging. 
3. Only include the most recent medication list, and improve the format 
of the electronic referral report. 
4. Enforce callback information be entered rather than relying on the 
sender to include the information. 
5. Improve the reliability of the system. 
6. Make sure everyone fully understands the functionality of the tools. 
7. Provide consistent training and support. 
8. Conduct regular user evaluation, and encourage feedback and 
critiques. 
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Drug-Limit Library Database and Research 
 
Research Team 
Faculty/Staff  PI: Poching DeLaurentis,Regenstrief Center for Healthcare 
Engineering, Purdue University 
Rich Zink, RCHE, Purdue University 
Yuehwern Yih, Industrial Engineering, Purdue University 
Student Kang-Yu Hsu, Industrial Engineering 
Healthcare Partners  TBD 
Research Direction 
Competencies Database 
 Data mining 
 Pattern and clustering analysis 
Research-to-Impact Phase B (Research and model development) 
Research Timeline May 2015–May 2016 
Project Summary 
Healthcare Problem The infusion drug-alert data and knowledge sharing within this IPI 
System-forged community of practice, along with the various 
reporting tools on the system, provide clinicians with in-depth 
information on medication infusions and their alerts. Many IPI System 
users, researchers, and organizations (e.g., Association for the 
Advancement of Medical Instrumentation, AAMI) see the value in 
creating a database of drug-limit libraries (DLLs) in addition to the 
alert database already in place. 
Research Objectives This project consists of two phases. Phase I aims to construct a DLL 
database of IPI System users’ drug limits. Phase II aims to utilize this 
database to understand the setting of drug limits and other relevant 
questions. 
1. Construction of a searchable drug-limit library/database and 
interactive display 
a. Identify and define what will be displayed in a DLL database, 
based on user (customer) requirements as basic view 
b. Identify the fields in a drug-limit library to be extracted or 
combined and methods 
 How to resolve format differences of DLLs from various 
pump vendors? 
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c. Design the dynamic drug-limit library/database ,display 
format, and functionality (tools) 
d. Implementation of the drug-limit library/database and 
interactive display 
e. Continuous improvement of the database based on user 
feedback 
2. Analysis of the drug limits 
a. Compare and contrast selected drug limits in the alert data 
vs nonalert data 
b. Study how drug limits evolve/converge over time 
c. Investigate the factors involved in setting drug limits 
Some specific questions may be: 
• Which drugs are reviewed the most? 
• Is there a convergence in limits for the community? 
• Do those that access the database make more changes? 
• What do the users view?  
• Do those that access the database more often decrease 
the number of alerts per device? This would be a cross-
database analysis, which requires data from the IPI 
database. 
• How are the alert patterns of different drug limits set for 
a particular drug? Compare those in the same facility and 
in different facilities. 
 
Methodology The construction of the DLL database will utilize database 
programming and visualization technologies and be based on 
HUBzero. Statistics, time-series analysis, pattern mining and machine 
learning techniques will be applied to study drug limits across 
hospitals, care units, drug types, and so on.   
Potential Impact A searchable drug-limit library database will allow clinicians and 
researchers to quickly find the limits hospitals set for a particular 
drug, compare how drug limits differ from one hospital or care unit to 
another, and how the limits evolved over time. The DLL database can 
also serve as the basis of what may later become a commercial-grade 
product and be used as a model for other similar applications. The 
analysis of drug limits across hospitals, care units, and drug types will 
enable the researchers to study the characteristics of various drug 
limits, how the IPI community’s knowledge diffuses and what its 
potential impact on clinical practice may be over time. 
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Project Update The team has already received some user requested database 
specifications, which are serving as the first set of system 
requirements of this DLL database. The graduate research assistant 
has started learning the HUBZero technologies. A project kickoff 
meeting took place on May 6, 2015, with the RCHE Co-PIs, Purdue 
engineering faculty, and graduate research assistant attending.  
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Drug-Limit Library Update Process 
 
Research Team 
Faculty/Staff  Poching DeLaurentis, Regenstrief Center for Healthcare Engineering, 
Purdue University 
Rich Zink, RCHE, Purdue University 
Yuval Bitan, Cognitive Technologies Laboratory, Chicago, IL 
Student Ana Isabel De la Hoz Armenta, Industrial Engineering, 
Universidad Nacional in Medellín  
Healthcare Partners  Eskenazi Health 
Research Direction 
Competencies Human factors 
 Data mining 
 Pattern and clustering analysis 
 Data visualization 
Research-to-Impact Phase B (Research and model development) 
Research Timeline March 2015–December 2015 
Project Summary 
Healthcare Problem Smart-infusion pumps are one of many types of medical devices that 
work in an information technology (IT) networked clinical 
environment. These pumps typically utilize a drug-limit library or 
guardrails to set limits on the dosage or rate of drug infusions. From 
time to time, changes or updates may be made to the drug-limit 
library, and they are done via wireless network in most modern 
facilities. Therefore, it becomes a priority to ensure the 
interoperability of these modern medical devices and information-
network technologies for it is a crucial part of safe medical-care 
delivery. However, not much is known whether designed 
interoperability works as well in practice. 
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Research Objectives The main objectives of this project are to understand and evalute the 
current infusion-pump update process, identify any best practices, 
and improve the reliability of the process. Our research questions 
include:  
 What is the current infusion-pump updating process?  
 Why may it take several weeks to update all the pumps 
in a facility?  
 What are the barriers to efficient and effective pump 
updates?  
 How can we improve the technology and human 
workflow to make the pump updates more reliable?  
 What can we learn from the drug limit library update 
process to inform the future of medical device 
interoperability in the healthcare working environment?  
Methodology We start by analyzing the version of library or data-set field in the IPI 
alert data (of a few hospitals) and how they change over time. We will 
work closely with clinicians and possibly vendors to understand the 
pump-update workflows of technology and human aspects. 
Potential Impact The results of this project may shed light on the broader question 
regarding the design and implementation of interoperability of future 
medical devices. 
Project Update We have started analyzing drug-limit library update history based on 
drug-alert data in our IPI database. Some conversations have taken 
place between the researchers, a pump vendor (Carefusion), and 
Eskenazi Health, regarding the general limit library-updating process 
and the overlapping of drug-limit libraries we discovered. Initial 
analysis has also begun to capture the characteristics of the pump-
updating process, such as the length of extended use of an inactive 
library version, frequency of updates in a facility, etc. In the 
meantime, we are refining the research questions for this project, as 
well as searching for potential publication outlets and conferences for 
this work. The data-sharing agreement between Purdue and Yuval 
Bitan has been established and executed as of March 31, 2015.  
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 The following figure is an example of the concurrent presence of 
multiple drug-limit libraries in infusion-alert data (of a single hospital).  
The graph shows the number of infusion alerts (indicated by marker 
size and color) that was generated by a specific version of the drug-
limit library (y-axis) on a given day from late 2013 to very early 2015 
(x-axis).  There seems to be more than five versions of the drug-limit 
library actively generating alerts in early October 2014.   
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Core and Extramural Funding 
 
   Year Regenstrief Foundation 
Core 
Extramural 
2013-2014 $2,000,000 $2,960,259 
2014-2015 $2,000,000 $541,619 
Subtotal $4,000,000 $3,501,878 
   
 
2015 Board Report Regenstrief Center for Healthcare Engineering
121













2015 Board Report Regenstrief Center for Healthcare Engineering
123




RCHE Metrics (2013–2018) 2013–2015 Progress 
Foundation President and Purdue President meet twice 
annually 
Phone call: April 10, 2014 
One to three seats on the Advisory Council Academic Advisory Committee 
(Deans):  
     May 28, 2014 
Academic Advisory Committee:   
     September 18 and 19, 2014 
     October 17, 2014 
RCHE research with an objective of impact will include 
research, validation, and dissemination partners. 
Partners for projects listed in 
Appendix C 
RCHE research conducted to achieve pre-impact 
objectives will involve research partners as is 
appropriate for the specific research. 
Partners for projects listed in 
Appendix C 
Research funding from major national funding sources 
awarding competitive grant applications 
Grants this period from:  
     National Science Foundation 
     U.S. Army (Medical Research 
Acquisition Activity) 
Publish research findings and reports in peer-reviewed 
journals. 
Publications listed in Appendix D 
Conduct research in transdisciplinary teams Ongoing 
Research projects with impact objectives include active 
dissemination by one or more dissemination partners 
Partners for projects listed in 
Appendix C 
Partners will evaluate the center during the grant 
period 
  
Evaluate research findings for impact on healthcare 
delivery 
  
Help sustain HSEA Serve as board member (Musselman) 
Maintain hub infrastructure for 
course and program dissemination 
Host at least one HSEA conference International webinar hosted 
February 26, 2015 
At least three multi-university proposals NSF ERC proposal submitted Fall 
2013, with University of Wisconsin—
Madison (not funded) 
Gap analysis/benchmarking against at least two other 
centers 
  
Evaluate effectiveness of research team in meeting 
objectives, dissemination success, and impact 
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Host two conferences annually 2013 
 IPI Virtual Conference, October 18 
2014 
 IPI Conference, May 21–22,  
  Indianapolis, IN 
 IPI Virtual Conference, September 
  19 
2015 
 IPI Virtual Conference, January 16 
 IPI Conference, April 22–23   
Host three nationally prominent speakers per year Karl Gumpper  
Bona Benjamin  
Thomas Pogge 
Marilyn Neder Flack 
Mike Brownlee 
Assess healthcare-delivery hub as an improvement 
and knowledge community tool 
*  
Submit annual operating budget Achieved 
Document management of foundation funds & 
submit monthly financial report 
Achieved 
Attain a core leverage ratio greater than or equal 
to 3.0 
0.7 (April 2015) 
  
  
* Witz, S., Buening, N. R., Catlin, A. C., Malloy, W., Kindsfater, J. L., Walroth, T., . . . Zink, R. 
(2014). Using informatics to improve medical device safety and systems thinking. Biomed 
















Search Committee Members 
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Regenstrief Center for Healthcare Engineering 
Director Search Committee 
 
William M. Tierney, M.D. 
President and CEO, Regenstrief Institute, Incorporated 
Chancellor’s Professor and Sam Regenstrief Professor of Health Services Research 
Associate Dean for Clinical Effectiveness Research 
Indiana University School of Medicine  
Elisa Bertino, PhD 
Director of Cyber Center 
Interim Director of CERIAS 
Professor of Computer Science 
Professor of Electrical and Computer Engineering (courtesy) 
Purdue University 
Hyunyi Cho, PhD 
Associate Dean for Research and Graduate Education, College of Liberal Arts 
Courtesy faculty, Department of Youth Development and Agricultural Education, College of Agriculture, 
Professor, Brian Lamb School of Communication 
Purdue University 
Rebecca Doerge, PhD 
Director, Departments of Agronomy and Statistics 
Department Head, Statistics 
Trent and Judith Anderson Distinguished Professor of Statistics 
Professor, Statistical Bioinformatics Center 
Purdue University 
Marietta L. Harrison, PhD 
Interim Director, Regenstrief Center for Healthcare Engineering in Discovery Park 
Special Advisor Strategic Initiatives, Office of the Executive Vice President for Research and Partnerships 
Associate Vice-President for Research 
Director, Oncological Sciences Center in Discovery Park 
Associate Director, Purdue Center for Cancer Research 
Professor, Medicinal Chemistry and Molecular Pharmacology 
Purdue University 
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David Hummels, PhD 
Dean, Krannert School of Management 
Professor, School of Economics 
Purdue University 
Martin Jischke, PhD 
President Emeritus 
Purdue University 
David McKinnis, PhD 
Director, Technical Assistance Program 
Assistant Vice President for Engagement 
Purdue University 
Ken Musselman, PhD 
Director, Strategic Collaboration, Regenstrief Center for Healthcare Engineering 
Purdue University 
Joseph Pekny, PhD 
Interim Director of Burton D. Morgan Center for Entrepreneurship 
Professor of Chemical Engineering 
Purdue University 
Cleveland Shields, PhD 
Director, Center on Poverty and Health Inequities (Regenstrief Center for Healthcare Engineering) 
Professor of Human Development and Family Studies, College of Health and Human Sciences 
Purdue University 
George Wodicka, PhD 
Regenstrief Center for Healthcare Engineering Director Search Committee Chair 
Professor and Head, Weldon School of Biomedical Engineering  
Professor, Electrical and Computer Engineering 
Purdue University 
Yuehwern Yih, PhD 
Director, Smart Systems and Operations Laboratory 
Regenstrief Center for Healthcare Engineering Faculty Scholar 
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Marietta Harrison Brief Biography 
 
Marietta L. Harrison was named Associate Vice President for Research in 
2009 and Special Advisor – Strategic Initiatives Office of Research and 
Partnerships in 2014 at Purdue University.  In this position she is charged with 
responsibility for various aspects of research administration, internal funding, 
internal research policies and aspects of research stewardship. 
Harrison is a professor in the Department of Medicinal Chemistry and Molecular 
Pharmacology and serves as the Director of the Oncological Sciences Center 
and Interim Director of the Regenstrief Center for Healthcare Engineering in 
Discovery Park and the Associate Director for the Purdue University Center for 
Cancer Research. Her research interests lay in the area of immune cell 
activation and the role of immunity in cancer surveillance. The Harrison 
laboratory studied the mechanisms underlying the function of the pivotal tyrosine kinase Lck and the group 
has published over 70 articles in peer-reviewed journals. 
Harrison served as a member of the NIH Experimental Immunology Study Section and as an ad hoc 
reviewer for the NIH Allergy and Immunology Study Section, the Transplantation, Tolerance and Tumor 
Immunology Study Section and various NIH Special Study Sections. She served two terms on the Editorial 
Board of the Journal of Biological Chemistry and as a standing member of the ASBMB Human Resource 
Committee. She is the recipient of the Lafayette Lions Purdue Cancer Research Award, 
Walther Cancer Institute “Collaborator of the Year Award” and is designated a 2009 Women of Purdue 
honoree. 
Harrison received a doctoral degree in biochemistry from the University of Wyoming in 1980 and holds a 
bachelor’s degree in chemistry from the University of New Hampshire. 
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Marietta Harrison CV 
 
Curriculum Vitae 
Marietta Lambert Harrison 
 
Professor of Medicinal Chemistry 
Department of Medicinal Chemistry and Molecular Pharmacology 
College of Pharmacy 
Purdue University 
West Lafayette, IN  47907 
Phone: 765-494-1442 
Email: harrisom@purdue.edu 
Interim Director, Regenstrief Center for Healthcare Engineering 




Director, Oncological Sciences Center 
Hall for Discovery Research and Learning, Discovery Park, Purdue University 
Associate Director, Purdue University Center for Cancer Research 
Hansen Life Sciences Research Building, Purdue University 
Special Advisor - Strategic Initiatives 
Office of the Executive Vice President for Research and Partnerships, Purdue University 
Training and Experience 
1966-1970    University of New Hampshire, B.A., Chemistry 
1970-1973 Research Technician, Department of Biophysics, Harvard University, 
Cambridge; Director: Bert L. Vallee, MD 
1973-1975 Research Technician, Department of Nephrology, University of Vermont, 
Burlington; Director: Michael J. Dunn, MD 
1975-1980 University of Wyoming, Laramie; Ph.D., Biochemistry; Advisor: Clarence L. 
Villemez, PhD 
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1980-1982 Postdoctoral Fellow, Division of Tumor Immunology, Fred Hutchinson Cancer 
Research Center, Seattle; Directors: Karl Erik Hellström, MD, PhD and Ingegerd 
Hellström, MD, PhD 
1983-1985 Visiting Assistant Professor, Department of Medicinal Chemistry and 
Pharmacognosy, Purdue University, West Lafayette, IN 
1986-1989 Assistant Research Scientist, Department of Medicinal Chemistry and 
Pharmacognosy, Purdue University 
1989-1993 Assistant Professor, Department of Medicinal Chemistry and Molecular 
Pharmacology, Purdue University 
1993-1999 Associate Professor, Department of Medicinal Chemistry and Molecular 
Pharmacology, Purdue University 
1999-present Professor, Department of Medicinal Chemistry and Molecular Pharmacology, 
Purdue University 
1996-1998 Assistant Director, Purdue University Center for Cancer Research 
1998-present Associate Director, Purdue University Center for Cancer Research 
2005-2007 Interim Director, Oncological Sciences Center, Discovery Park, Purdue 
University 
2007-present Director, Oncological Sciences Center, Discovery Park, Purdue University 
2009-2014 Associate Vice President for Research, Purdue University 
2011-present Interim Deputy Director Bindley Bioscience Center, Discovery Park 
2014-present Special Advisor-Strategic Initiatives, Office of the Executive Vice President for 
Research and Partnerships, Purdue 
2015 Interim Director, Regenstrief Center for Healthcare Engineering 
Professional Activities 
1994 Member, NIH Special Study Section 2(ZRG7-SSS-2MGN-BLS) 
1995-2000 Editorial Board, Journal of Biological Chemistry 
2003-2008 Editorial Board, Journal of Biological Chemistry 
1996 NIH Allergy and Immunology Study Section (Ad Hoc) 
1996-1999 American Society for Biochemistry and Molecular Biology (ASBMB) Human 
Resources Committee 
1997-2001 Member, NIH Experimental Immunology Study Section 
2015 Board Report Regenstrief Center for Healthcare Engineering
136
2002 Member, NIH Special Study Section ZRG1 EI (02)  
2003 Member, NIH Special Study Section ZRG1 SSSF-F (03) 
2003 NIH Experimental Immunology (EI) Study Section (Ad Hoc) 
2005 Member, NIH Special Study Section ZRG1 IMM-A 
2006 NIH Transplantation, Tolerance and Tumor Immunology Study Section (Ad Hoc) 
2008 NIH Cellular and Molecular Immunology-A Study Section (Ad Hoc) 
2009 NIH Transplantation, Tolerance and Tumor Immunology Study Section (Ad Hoc) 
Professional Societies 
American Society for Biochemistry and Molecular Biology 
American Association for Cancer Research 
American Society for Microbiology 
Honors and Fellowships 
Gamma Sigma Delta, Honorary Society, University of Wyoming, 1979 
Recipient, Cancer Research Institute Postdoctoral Fellowship, 1980-1981 
Recipient, National Institutes of Health, National Research Service Award, 1981-1983 
Lions Club Purdue Cancer Research Award, 1988 
SNPhA (Student National Pharmaceutical Association, Minority Students) Appreciation Plaque 
(1998) 
Purdue Seed for Success Award, 2003 
Walther Cancer Institute Collaborator of the Year Award, 2007 
Purdue Seed for Success Award, 2007 
Purdue Seed for Success Award, 2008 
SNPhA (Student National Pharmaceutical Association, Minority Students) Appreciation Plaque 
(2009) Woman of Purdue honoree by the Barbara Cook Chapter of Mortar Board, 2009 
Community Service 
2015   Clinical Research Board, IU Health Arnett 
  




Interim Director, Regenstrief Center for Healthcare Engineering 
Director, Oncological Sciences Center, Discovery Park 
Associate Director, NCI-designated Purdue University Center for Cancer Research 
Special Advisor – Strategic Initiatives, Office of the Executive Vice President for Research and 
Partnerships 
Executive Vice President for Research and Partnerships liaison to the IN School of Medicine 
Chair, Research Faculty Working Group 
Purdue Representative, Federal Demonstration Partnership 
Purdue representative to the Indiana Biosciences Research Institute 
Search Committee, Department Head, Medicinal Chemistry and Molecular Pharmacology 
Search Committee, Director of the Regenstrief Center for Healthcare Engineering 
Search Committee, Executive Director Indiana Center for Musculoskeletal Health, Indiana 
University School of Medicine 
Search Committee, Pharmacy Practice Assistant Professor(s) 
Internal Steering Committee, Women’s Global Health Institute, Purdue University 
Past Five Years: 
Search Committee, Associate Vice President for Research, Regulatory Affairs 
Member, Indiana CTSI Core Oversight Committee 
Member, Internal Advisory Committee, Susan G. Komen for the Cure® Tissue Bank 
at the IU Simon Cancer Center 
Search Committee (Chair), Associate Dean for Research and Graduate Programs, College of 
Health and Human Sciences 
Search Committee, Associate Dean of Research and Graduate Education, College of Science 
(2011) 
Search Committee, Director, Birck Nanotechnology Center in Discovery Park (2011) 
Chair, PUBAMS Spring 2010 International Membranes Symposium 
Selected Previous Service: 
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Co-chair, Purdue University Strategic Planning Committee, Large Scale Research and 
Infrastructure (appointed by President France Córdova) (2008) 
Search Committee, Vice President for Research, Purdue University (appointed by President 
France Córdova) (2008) 
Steering Committee, Cancer-Oncology Summit (IN Health Industry Forum) (2008) 
Search Committee, Director Purdue Cancer Center (2006) 
Sigma Xi (Purdue Chapter), Executive Committee (2002-2006) 
Search Committee, Director Purdue Cancer Center (2005) 
Minority Advocacy Committee, School of Pharmacy (1993-2001; 2003-2005)  
Departmental (MCMP) Executive Committee (2001-2005) 
PULSe (Purdue University Life Sciences Interdisciplinary Graduate program) Planning 
Subcommittee (2003) 
MCMP Cumulative Examination Committee (2002-2005) 
MCMP Curriculum Committee (1999-2004) 
Discovery Park Task Force Strategic Planning Committee (2002) 
Department of Medicinal Chemistry and Molecular Pharmacology Strategic Planning Committee 
(2002) 
Faculty Advisor, SNPhA (Student National Pharmaceutical Association, Minority Students) 
(1993-1996; 2002-2005) 
Faculty Advisor and Mentor, Purdue Initiative for Minority Student Development (IMSD) (1996-
2000) 
Examining Committee BMB (renamed PULSe, Interdisciplinary Life Sciences Graduate Training 
Program) (1990-1996) 
Graduate Opportunity Fellowship Committee (formerly Women, Black and Other Ethnic 
Minorities Committee) 1991-1996 
Purdue Community Relations 
Community Cancer Network Board of Directors; Lafayette, IN (2008-2013) 
Cancer Research Clinical Partnership Program; Co-founder with Wael Harb, MD; Lafayette, IN 
(2006-present) 
Cancer Culture and Community Program; Founder; Greater Lafayette Community, IN (2006-
present) 
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Publications 
1.   Staley, R., Dunn, M.J., and Harrison, M. (1976) Characterization of prostaglandin 
production in tissue culture of rat renal medullary cells, Prostaglandins 12, 27-49. 
2.   Harrison, M.L. and Villemez, C.L. (1981) Protein glycosylation is required for the 
proliferation of mitogen activated lymphocytes, J. Immunol. 127, 1616-1617. 
3.   Casnellie, J.E., Harrison, M.L., Pike, L.J., Hellström, K.E., and Krebs, E.G. (1982) 
Phosphorylation of synthetic peptides by a tyrosine protein kinase from the particulate 
fraction of a lymphoma cell line, Proc. Natl. Acad. Sci. USA 79, 282-286. 
4.   Casnellie, J.E., Harrison, M.L., Hellström, K.E., and Krebs, E.G. (1982) A lymphoma protein 
with an in vitro site of tyrosine phosphorylation homologous to that in pp60src, J. Biol. Chem. 
256, 13877-13879. 
5.   Casnellie, J.E., Harrison, M.L., Pike, L.J., Hellström, K.E., and Krebs, E.G. (1983) A 
Maloney murine leukemia virus induced cell line expressing elevated levels of tyrosine 
protein kinase activity, J. Biol. Chem. 258, 10738-10742. 
6.   Geahlen, R.L. and Harrison, M.L. (1984) Induction of a substrate for casein kinase II during 
lymphocyte mitogenesis, Biochim. Biophys. Acta 804, 169-175.  
7.   Harrison, M.L., Low, P.S., and Geahlen, R.L. (1984) T and B lymphocytes express distinct 
tyrosine protein kinases, J. Biol. Chem. 259, 9348-9350. 
8.   Mason, D.L., Harrison, M.L., and Geahlen, R.L. (1985) Properties of a tyrosine protein 
kinase from calf thymus.  Response to Ionic strength and divalent cations, Biochim. 
Biophys. Acta 829, 22l-228. 
9.   Geahlen, R.L., Anostario, M., Low, P.S., and Harrison, M.L. (1986) Detection of protein 
kinase activity in sodium dodecyl sulfate-polyacrylamide gels, Anal. Biochem. 153, 151-
158. 
10.   Geahlen, R.L. and Harrison, M.L. (1986) Detection of a novel lymphocyte protein-tyrosine 
kinase by renaturation in polyacrylamide gels, Biochem. Biophys. Res. Commun. 134, 963-
969. 
11.   Zioncheck, T.F., Harrison, M.L., and Geahlen, R.L. (1986) Purification and characterization 
of a protein-tyrosine kinase from bovine thymus, J. Biol. Chem. 261, 15637-15643. 
12.  Low, P.S., Allen, D.P., Chari, P., Zioncheck, T.F., Geahlen, R.L. and Harrison, M.L. (1987) 
Tyrosine phosphorylation of Band 3 inhibits peripheral protein binding, J. Biol. Chem. 262, 
4592-4596. 
13.   Zioncheck, T.F., Harrison, M.L., Isaacson, C. and Geahlen, R.L. (1988) Generation of an 
active lymphocyte protein-tyrosine kinase by proteolysis, J. Biol. Chem. 263, 19195-19202. 
14.   Mahrenholz, A.M., Votaw, P., Roach, P.J., DePaoli-Roach, A.A., Zioncheck, T.F., Harrison, 
M.L. and Geahlen, R.L. (1988) Phosphorylation of glycogen synthase by a bovine protein-
tyrosine Kinase, p40, Biochem. Biophys. Res. Commun. 155, 52-58. 
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15.   Willardson, B.M., Thevenin, B.J-M., Harrison, M.L., Kuster, W.M., Benson, M.D., and Low, 
P.S. (1989) Localization of the ankyrin-binding site of erythrocyte membrane protein, Band 
3, J. Biol. Chem. 264, 15893-15899. 
16.  Low, P.S., Willardson, B.M., Thevenin, B., Kannan, R., Mehler, E., Geahlen, R.L., and 
Harrison, M.L. (1989) "The Other Functions of Erythrocyte Membrane Band 3," in Anion 
Transport Protein of the Red Cell Membrane" (N. Hamasaki and M. Jennings, eds.) 
Elsevier Press.  
17.   Geahlen, R.L. and Harrison, M.L. (1990), "Protein-Tyrosine Kinases," in Peptides and 
Protein Phosphorylation (Kemp, B.E., ed.) CRC Press, FL pp. 239-253. 
18.   Low, P.S., Geahlen, R.L., Mehler, E., and Harrison, M.L. (1990) Extracellular control of 
erythrocyte metabolism mediated by a cytoplasmic tyrosine kinase, Biomed. Biochim. Acta 
49, S135-S140. 
19.   Vila, J., Payne, M., Zioncheck, T., Harrison, M.L., Itarte, E., and Weber, M.J. (1990) 
Phosphorylation and activation of p40 tyrosine kinase by casein kinase I, FEBS Lett. 264, 
21-24. 
20.   Anostario, M. Jr., Harrison, M.L., and Geahlen, R.L. (1990) Immunochemical detection of 
adenine nucleotide-binding proteins with antibodies to 5'-p-fluorosulfonylbenzoyladenosine, 
Anal. Biochem. 190, 60-65. 
21.   Harrison, M.L., Rathinavelu, P., Arese, P., Geahlen, R.L., and Low, P.S. (1991) Role of 
Band 3 phosphorylation in the regulation of erythrocyte glycolysis, J. Biol. Chem. 266, 
4106-4111. 
22.   Wang, Q., Srinivas, P.R., Harrison, M.L., and Geahlen, R.L. (1991) Partial purification and 
characterization of the lck protein-tyrosine kinase from bovine thymus, Biochem. J. 279, 
567-574. 
23.   Hutchcroft, J.E., Harrison, M.L. and Geahlen, R.L. (1991) B lymphocyte activation is 
accompanied by phosphorylation of a 72 kDa protein-tyrosine kinase, J. Biol. Chem. 266, 
14846-14849. 
24.   Hutchcroft, J.E., Anostario, M. Jr., Harrison, M.L., and Geahlen, R.L. (1991) Renaturation 
and assay of protein kinases after electrophoresis in SDS-polyacrylamide gels, Methods in 
Enzymology 200, 417-423. 
25.   Srinivas, P.R., Ford, C.E., and Harrison, M.L. (1991) Sodium orthovanadate inhibits 
mitogen induced T cell proliferation by preventing IL-2 responsiveness, Allergy and 
Immunol. (Life Sci. Adv.) 10, 61-67. 
26.   Wang, Q., Smith, J.B., Harrison, M.L., and Geahlen, R.L. (1991) Identification of tyrosine 67 
in bovine brain myelin basic protein as a specific phosphorylation site for thymus p56lck, 
Biochem. Biophys. Res. Commun. 178, 1393-1399.  
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27.   Hutchcroft, J.E., Harrison, M.L., and Geahlen, R.L. (1992) Association of the 72 kDa 
protein-tyrosine kinase PTK72 with the B cell antigen receptor, J. Biol. Chem. 267, 8613-
8619. 
28.   Srinivas, P.R., Hutchroft, J.E., Aube, B.D., and Harrison, M.L. (1992) p56lck stably 
associates with a 115 kDa substrate, Biochem. Biophys. Res. Commun. 186, 537-542. 
29.   Harrison, M., Isaccson, C., Rathinavelu, P., and Low, P.S. (1992) Resealing of protein 
tyrosine kinase substrates into human erythrocytes by rapid freezing and thawing in liquid 
nitrogen, Adv. Exp. Med. Biol. 326, 111-117.   
30.   Burg, D.L., Harrison, M.L. and Geahlen, R.L. (1993) Cell cycle-specific activation of the 
PTK72 protein-tyrosine kinase in B lymphocytes, J. Biol. Chem. 268, 2304-2306. 
31.   Paige, L.A., Nadler, M.J.S., Harrison, M.L., Cassady, J.M., and Geahlen, R.L. (1993) 
Reversible palmitoylation of the protein-tyrosine kinase p56lck, J. Biol. Chem. 268, 8669-
8674.  
32.   Low, P.S., Rathinavelu, P., and Harrison, M. (1993) Regulation of glycolysis via reversible 
enzyme binding to the membrane protein, Band 3, J. Biol. Chem. 268, 14627-14631. 
33.   52.  Nadler, M.J.S., Harrison, M.L., Ashendel, C.L., Cassady, J.M., and Geahlen, R.L. 
(1993) Treatment of T cells with 2-hydroxymyristic acid inhibits the N-myristoylation and 
alters the stability of p56lck, Biochemistry 32, 9250-9255. 
34.   Harrison, M.L., Isaacson, C.C., Burg, D.L., Geahlen, R.L., and Low, P.S. (1994) 
Phosphorylation of human erythrocyte Band 3 by endogenous p72syk, J. Biol. Chem. 269, 
955-959. 
35.   Burg, D.L., Furlong, M.T., Harrison, M.L., and Geahlen, R.L. (1994) Interactions of Lyn with 
the antigen receptor during B cell activation, J. Biol. Chem. 269, 28136-28142. 
36.   Ford, C.E., Furlong, M.T., Geahlen, R.L., and Harrison, M.L. (1994) Signaling-induced 
association of a tyrosine phosphorylated 36 kDa protein with p50csk, J. Biol. Chem. 269, 
30378-30385. 
37.   Peters, J.D., Furlong, M.T., Asai, D.J., Harrison, M.L., and Geahlen, R.L. (1996) Syk, 
activated by cross-linking the B-cell antigen receptor, localizes to the cytosol where it 
interacts with and phosphorylates α-tubulin on tyrosine, J. Biol. Chem. 271, 4755-4762. 
38.   Pathan, N.I., Geahlen, R.L., and Harrison, M.L. (1996) Lck associates with and is 
phosphorylated by Cdc2, J. Biol. Chem. 271, 27517-27523. 
39.   Pathan, N.I., Ashendel, C.L., Geahlen, R.L. and Harrison, M.L. (1996) Activation of T-cell 
Raf-1 at mitosis requires the protein tyrosine kinase Lck, J. Biol. Chem. 271, 30315-30317.  
40.   Furlong, M.T., Mahrenholz, A.M., Kim, K.-H., Ashendel, C.L., Harrison, M.L., and Geahlen, 
R.L. (1997) Identification of the major sites of autophosphorylation of the murine protein-
tyrosine kinase Syk, Biochim. Biophys. Acta 1355, 177-190. 
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41.   Keshvara, L.M., Isaacson, C., Harrison, M.L., and Geahlen, R.L. (1997) Syk activation and 
dissociation from the B-cell antigen receptor is mediated by phosphorylation of tyrosine-
130, J. Biol. Chem. 272, 10377-10381. 
42.   Oberlies, N.H., Croy, V.L., Harrison, M.L., and McLaughlin, J.L. (1997) The annonaceous 
acetogenin Bullatacin is cytotoxic against multidrug resistant human mammary 
adenocarcinoma cells, Canc. Lett. 115, 73-79. 
43.  Hutchcroft, J.E., Anostario, M. Jr., Harrison, M.L., and Geahlen, R.L. (1998) "Renaturation 
and assay of protein kinases after electrophoresis in SDS-polyacrylamide gels," in Protein 
Phosphorylation (Sefton, B.M. and Hunter, T., eds.) Academic Press, pp. 169-175. 
44.   Keshvara, L.M., Isaacson, C., Yankee, T.M., Sarac, R., Harrison, M.L. and Geahlen, R.L. 
(1998) Syk- and Lyn-dependent phosphorylation of Syk on multiple tyrosines following B-
cell activation includes a site that negatively regulates signaling, J. Immunol. 161, 5276-
5283.  
45.  Fernandez, J.A., Keshvara, L.M., Peters, J.D., Furlong, M.T. Harrison, M.L. and Geahlen, 
R.L. (1999) Phosphorylation- and activation-independent association of the tyrosine kinase 
Syk and the tyrosine kinase substrates Cbl and Vav with tubulin in B-cells, J. Biol. Chem. 
274, 1401-1406.  
46.   Miller, L.A., Kinch, M.S., Hong, J., Harrison, M.L., and Geahlen, R.L. (1999) The 
Engagement of β1 integrins on promonocytic cells promotes phosphorylation of Syk and 
formation of a protein complex containing Lyn and β1 integrin, Eur. J. Immunol. 29, 1426-
1434.  
47.   Yankee, T.M., Keshvara, L.M., Sawasdikosol, S., Harrison, M.L., and Geahlen, R.L. (1999) 
Inhibition of signaling through the B cell antigen receptor by the proto-oncogene product, c-
Cbl, requires Syk tyrosine 317 and the c-Cbl phosphotyrosine-binding domain, J. Immunol. 
163, 5827-5835. 
48.   Gaul, B.S., Harrison, M.L., Geahlen, R.L., Burton, R.A., and Post, C.B. (2000) Substrate 
recognition by the Lyn protein-tyrosine kinase: NMR structure of the immunoreceptor 
tyrosine-based activation motif signaling region of the B-cell antigen receptor, J. Biol. 
Chem.  275, 16174-16182. 
49.   Ma, H., Yankee, T.M., Hu, J., Asai, D.J., Harrison, M.L., and Geahlen, R.L. (2001) 
Visualization of Syk-antigen receptor interactions using green fluorescent protein: 
differential roles for Syk and Lyn in the regulation of receptor capping and internalization, J. 
Immunol. 166, 1507-1516.     
50.   Hawash, I.Y., Kesavan, K.P., Magee, A.I., Geahlen, R.L. and Harrison, M.L. (2002) The Lck 
SH3 domain negatively regulates localization to lipid rafts through an interaction with c-Cbl, 
J. Biol. Chem. 227, 5683-5691. 
51.  Hawash, I.Y., Hu, X.E., Adal, A., Cassady, J.M., Geahlen, R.L., and Harrison, M.L. (2002) 
The oxygen-substituted palmitic acid analog, 13-oxypalmitic acid, inhibits Lck localization to 
lipid rafts and T cell signaling, Biochim. Biophys. Acta 1589, 140-150. 
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52.   Kesavan, K.P., Isaacson, C.C., Ashendel, C.L., Geahlen, R.L., and Harrison, M.L. (2002) 
Characterization of the in vivo sites of serine phosphorylation on Lck identifying serine 95 
as a site of mitotic phosphorylation, J. Biol. Chem. 277, 14666-14673. 
53.   Hong, J.J., Yankee, T.M., Harrison, M.L. and Geahlen, R.L. (2002) Regulation of signaling 
in B Cells through the phosphorylation of Syk on linker-region tyrosines. A mechanism for 
negative signaling by the Lyn tyrosine kinase, J. Biol. Chem. 277, 31703-31714. 
54.   Moore, L.L., Fulton, A.M., Harrison, M.L., and Geahlen, R.L. (2004) Anti-sulfonylbenzoate 
antibodies as a tool for the detection of nucleotide-binding proteins for functional 
proteomics, J. Proteome Res. 3, 1184-1190. 
55.   Geahlen, R.L., Handley, M.D. and Harrison, M.L. (2004) Molecular Interdiction of Src family 
kinase signaling in hematopoietic cells, Oncogene 23, 8024-8032. 
56.   Moon, K.D., Post, C.B., Durden, D.L., Zhou, Q., De, P., Harrison, M.L., and Geahlen, R.L. 
(2005) Molecular Basis for a direct interaction between the Syk protein-tyrosine kinase and 
phosphoinositide 3-kinase, J. Biol. Chem. 280, 1543-1551.   
57.   Zheng, Y., Balakrishnan, V., Buzzard, G., Geahlen, R., Harrison, M., and Rundell, A. (2005) 
Modeling and analysis of early events in T lymphocyte antigen-activated intracellular-
signaling pathways, J. Comput. Appl. Math. 184, 320-341.   
58.   Zhou, F., Hu, J., Ma, H., Harrison, M.L., and Geahlen, R.L. (2006) Nucleocytoplasmic 
trafficking of the Syk protein-tyrosine kinase, Mol. Cell. Biol. 26, 3478-3491.   
59.   Oh, H., Ozkirimli E., Shah, K., Harrison, M.L., and Geahlen, R.L. (2007) Generation of an 
analog-sensitive Syk tyrosine kinase for the study of signaling dynamics from the B cell 
antigen receptor, J. Biol. Chem. 282, 33760-33768.   
60.   Krzysiak, A.J., Rawat, D.S., Scott, S.A., Pais, J.E., Handley, M., Harrison, M.L., Fierke, 
C.A., and Gibbs, R.A. (2007) Combinatorial modulation of protein prenylation, ACS Chem. 
Biol. 2, 385-389. 
61.   Donahue, M.M., Zhang, W., Harrison, M.L., Hu, J., and Rundell, A.E. (2007) Employing 
optimization and sensitivity analyses tools to generate and analyze mathematical models of 
T cell signaling events, AIP Conf. Proc. 953, 43-63.    
62.   Li, M, Ong, S.S., Rajwa, B., Thieu, V.T., Geahlen, R.L., and Harrison, M.L. (2008) The SH3 
domain of Lck modulates TCR-dependent activation of Erk through activation of Raf-1, Mol. 
Cell Biol. 28, 630-641. 
63.   Jennings, B.C., Nadolski, M.J.Ling, Y., Baker, M.B., Harrison, M.L., Deschenes, R.J., and 
Linder, M.E. (2009) 2-Bromopalmitate and 2-(2-hydroxy-5-nitro-benzylidene)-
benzo[b]thiophen-3-one inhibit DHHC-mediated palmitoylation in vitro, J. Lipid Research 
50, 233-242. 
64.   Paris, LL., Hu, J., Galan, J., Ong, S.S., Ma, H., Tao, W.A., Harrison, M.L., and Geahlen, 
R.L. (2010) Regulation of Syk by phosphorylation on serine in the linker insert, J. Biol. 
Chem. 285, 39844-39854. PMC3000966 
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65.   Majmudar, J.D., Hodges-Loaiza, H.B., Hahne, K., Donelson, J.L., Song,J., Shrestha, L., 
Harrison, M.L., Hrycyna, C.A., and Gibbs, R.A. (2012) Amide-modified prenylcysteine 
based Icmt inhibitors: Structure-activity relationships, kinetic analysis and cellular 
characterization, Bioorg Med. Chem. 20, 283-295. PMID: 22142613 
66.   Perley, J., Mikolajczak, J., Dinh, V., Buzzard, G., Harrison, M.L., and Rundell, A. (2012) 
Systematically Manipulating T-Cell Signaling Dynamics via Multiple Model Informed Open-
Loop Controller Design, 51st IEEE Conference Decision and Control, 380-385. 
67.   Cai, H., Chiorean, E.G., Chiorean, M.V., Rex, D.K., Robb, B.W., Hahn, M.N., Liu, Z., 
Loehrer, P. J., Harrison, M.L., and Xu, Y. (2013) Elevated Phospholipase A2 Activities in 
Plasma Samples from Multiple Cancers, PLOS ONE, 8 (PMCID: PMC3579817)  
68.   Perley, J.P., Mikolajczak, J., Buzzard, G.T., Harrison, M.L., Rundell, and Rundell, A.E. 
(2014) Resolving Early Signaling Events in T-Cell Activation Leading to IL-2 and FOXP3 
Transcription, Processes, 2, 867-900 
69.   Perley, J.P., Mikolajczak J., Harrison M.L., Buzzard G.T., and Rundell AE (2014) Multiple 
Model-Informed Open-Loop Control of Uncertain Intracellular Signaling Dynamics. PLoS 
Comput Biol 10(4): e1003546. doi: 10.1371/journal.pcbi.1003546  
70.    Chen, C., Deng L., Wei, S., Gowda G.A.N., Gu, H., Chiorean, E.G., Zaid, M.A., Harrison, 
M.L., Pekny, J.F., Loehrer, P.J., Zhang, D., Zhang, M., and Raftery, D. (2015) Exploring 
Metabolic Profile Differences between colorectal Polyp Patients and Controls Using 
Seemingly Unrelated Regression, J. Prot. Res., In Press  
Manuscripts in Preparation 
1. Handley, M., Gibbs, R.A., Geahlen, R.L. and Harrison, M.L. “Localization and function of 
the N-Ras and K-Ras isoforms in T cells”  
2. Beckham, M., Post, C. Tao, A., Geahlen, R.L., and Harrison, M.L. “ The effect of the 
phosphorylation of serine 59 on the conformation of Lck and the binding of the SH2 
domain”  
3. Ong, S.S., Li, M., Galan, J., Tao, A.W., Geahlen, R.L., and Harrison, M.L. “SH3 domain 
regulated Lck trafficking and localization”. 
4. Vázquez, M.L., Geahlen, R.L., and Harrison, M.L. “Nck is a Unique Binding Partner of Lck 
and the Nck/Lck Interaction is regulated by the phosphorylation of serine 59 in Lck”  
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Major Research Funding  
CURRENT 
Walther Cancer Foundation 06/1/2010-5/31/2016 
Walther Oncology Physical Sciences & Engineering Research Embedding Program 
The goal of this program is to create research embedding teams consisting of newly minted 
engineering or physical sciences postdoctoral fellow, a medical fellow, IUSCC oncology faculty 
mentor and a Purdue/Physics/Chemistry/Engineering faculty mentor.  
Role: PI 0.0 cal. mon. 
 
Walther Cancer Foundation 06/01/2010-05/31/2016 
Cancer Care Engineering Genomics Project  
This award supports the next-gen sequence analysis of colon cancer tissue samples and the 
data analysis and modeling of the data for biomarkers of risk of disease and progression. 
Role: PI 0.0 cal. mon. 
 
NIH 5P30 CA23168 National Cancer Institute 07/01/10-06/30/15 
Cancer Center Support Grant  
This is an institutional grant that supports the Purdue Center for Cancer Research programs and 
resources.  
Role: Co-PI, 0.6 cal. mon. (PI, Ratliff) 
Major Research Funding  
PREVIOUS 
NSF:DMS/NIH:NIGMS DMS: 0900277 (Joint Program) 09/01/2009-8/31/2013 
Quantitative Design of Experiments to Predictably Alter Intracellular Signaling Dynamics 
The project focuses on generating predictive mathematical models for describing signaling 
pathways in cells. 
Role: Co-PI, 1.2 cal. mon. (PI, Rundell) 
 
NIH CTSA SUPPLEMENT 3UL1RR025761-4S2 9/01/2011-4/30/2012 
Infrastructure to Enable Community Based Clinical Trials for Biomarker Discovery 
This project focuses on developing an interfacing infrastructure to capture and deposit e-medical 
records at the community-based IUHealth Arnett hospital into the Purdue University cceHUB 
database. 
Role: Purdue PI; 0.6 cal. mon (CTSI PI Anantha Shekhar, Indiana University) 
 
DOD USAMRMC (CDMRP) 09107003   2/07/2010-1/31/2012 
Cancer Care Engineering (CCE) II 
This project enlarges the patient base for CCE, increases the biological assays to eight, and 
expands CCE to include a cost benefit analysis of colon cancer prevention screenings and 
delivery of colon cancer care. 
Role: Co-Purdue PI with Pekny; 0.3 cal. mon. (PI Loehrer, Indiana University) 
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DOD USAMRMC (CDMRP) W81XWH-08-1-0065   2/08/2008-3/07/2011 
Cancer Care Engineering (CCE) 
This project focuses on identifying “molecular signatures” of colon cancer in the blood and 
tissues of colon cancer patients by performing six simultaneous assays for detecting colon 
cancer biomarkers and creating a single cyber infrastructure to store, analyze, integrate, and 
model annotated clinical data.  
Role: Co-Purdue PI with Pekny; (Loehrer PI) 
 
R01 NIHCA37372-27 (Geahlen PI, Harrison Co-PI) 02/01/2007-01/31/2011 
Tyrosine Protein Kinase and Lymphocyte Activation 
These studies focus on the role of the tyrosine kinase Syk in mediating signaling through 
the B cell receptor. 
 
Regenstrief Foundation 07/01/2007-6/30/2010 
Developing a Hierarchical System Based Approach to Improving Cancer Care: 
Establishing an Indiana Prototype for Next-Generation Colorectal Cancer Care  
Role: Co-PI (Pekny PI) 
 
100-1234-00-0005 Walther Cancer Foundation 03/01/ 2007-05/31/2010 
Cancer Care Engineering Infrastructure 
This award supports the project management infrastructure for the Cancer Care Engineering 
project.   
Role: PI  
 
R56 NIHCA078819-09 Gibbs (PI) 09/01/06- 06/30/10 
Chemical Probes of Protein Prenylation 
These studies focus on the development of tools for studying protein farnesylation  
Role: Co-PI (Gibbs PI)  
 
R01 NIHGM48099-10 Harrison (PI) 9/30/2003-8/31/2008 
Characterization of Lck and Associated Proteins 
The studies address the role of the intramembrane localization and serine phosphorylation in the 
function of the protein tyrosine kinase Lck.   
 
R01 NIHCA37372-26 02/01/07- 01/31/11 
Tyrosine Protein Kinase and Lymphocyte Activation    
Role: Co-PI; 1.2 months (calendar year); (Geahlen PI) 
 
R56 NIHCA078819-09 09/01/06 – 06/30/10 
Chemical Probes of Protein Prenylation  
Role: Co-PI; 0.6 months (calendar year); (Gibbs PI)  
 
R01 NIHGM48099 08/01/02-07/31/08 
Characterization of Lck and Associated Proteins 
(P.I., M. L. Harrison, Co-P.I., R.L. Geahlen) 
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R01 NIHCA37372 02/01/02-01/31/07  
Tyrosine Protein Kinases and Lymphocyte Activation  
(P.I., R.L. Geahlen, Co-P.I., M.L. Harrison)  
 
R01 NIHGM48099  /01/98-07/31/02 
Characterization of Lck and Associated Proteins  
(P.I., M. L. Harrison, Co-P.I., R.L. Geahlen) 
 
R01 NIHCA37372 02/01/97-01/31/02 
Tyrosine Protein Kinases and Lymphocyte Activation  
(P.I., R.L. Geahlen, Co-P.I., M.L. Harrison)  
 
NIHR01 GM 48099 08/01/92-07/31/96  
Characerization of p56lck and Associated Proteins  
P.I., M.L. Harrison, Co-P.I., R.L. Geahlen) 
 
NIHR01 CA37372 4/01/92-02/31/97   
Tyrosine Protein Kinases and Lymphocyte Activation  
(P.I., R.L. Geahlen, Co-P.I., M.L. Harrison) 
 
NIHR01 GM40983 12/01/88-11/30/93 
Red Cell Tyrosine Kinases and Regulation of Metabolism  
(P.I., P.S. Low, Co-P.I.’s, M.L. Harrison and R.L. Geahlen) 
 
NIHR01 CA37372 1/5/87-2/28/92 
Tyrosine Protein Kinases and Lymphocyte Activation  
(P.I., R.L. Geahlen, Co-P.I., M.L. Harrison) 
 
NIHP01 CA36761  9/1/85-8/31/88 
Membrane Program Project (P.I., D.J. Morré) 
Tyrosine Phosphorylation and Hepatocyte Transformation  
(Project 3 P.I.’s, M.L. Harrison and R.L. Geahlen). 
 
NIHR01 CA37372 03/15/84-02/28/87 
Tyrosine Protein Kinases and Lymphocyte Activation  
(P.I., R.L. Geahlen, Co-P.I., M.L. Harrison) 
Trainees 
Previous graduate students      Degree  Year 
Carolyn Ford*   Ph.D.   1995 
Nuzhat Pathan   Ph.D.   1996 
Brian Skaggs    M.S.   1996 
Robyn Midwinter   M.S.   1997 
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José Fernandez*   Ph.D.   1999 
Kamala Kesavan   Ph.D.   1999 
Carla Edge**    Ph.D.   2000 
Zhongwen (Cindy) Yu  M.S.   2001 
Ibrahim Hawash   Ph.D.   2002 
Manqing Li    Ph.D.   2004 
Amy Krans    M.S.   2007 
Meredith Baker   Ph.D.   2007 
Mariá Luz Vázquez   Ph.D.   2007 
Misty Handley***   Ph.D.   2007 
Maria Mogafegh   M.S.   2009 
Su Sien Ong    Ph.D.   2010 
Judith Mikolajczak   Ph.D.   2012 
*Awarded NIH Predoctoral Minority Fellowships   
** ASBMB travel fellowship, CIC fellowship 
*** Jenkins Knevel Outstanding Graduate Research Award, School of Pharmacy 2005 
Currently I serve on 3 Graduate Advisory Committees and have served on over 60 in my tenure 
at Purdue 
Postdoctoral Fellows  Current Position 
Pothur R. Srinivas  Program Director, Division of Cardiovascular Diseases 
    National Heart, Lung and Blood Institute, NIH 
Anissa Buckner  Assistant Professor, Department of Ophthalmology, 
    University of Arkansas 
Judith Mikolajczak    
Teaching experience 
I have taught at Purdue University since 1987 in various chemistry, biochemistry, immunology 
and cancer courses. Below is list of the courses in which I have participated. 
BCHM 322*, “Analytical Biochemistry” 2 credits (1987) 
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MDCH 660, “Cancer Research I” 2 credits (1987) 
MDCH 310, “Quantitative Medicinal & Chemical Analysis” 3 credits (1987-1997) 
MDCH 401, “The Nature of Cancer” 1 credit (1987-present) 
MDCH 422*, “Immunology” 3 credits (1989-2007) 
BIOL 221, “Introduction to Microbiology” 4 credits (1990) 
MCMP 409/302, “Integrated Laboratory” 2 credits (1994-2002) 
MCMP 690P*, “Seminar in Signaling and Phosphorylation” I credit (1995-1997) 
VPB 620, “Advanced Immunology” 2 credits (1996-2005) 
LCME 504, “Molecular Biology of the Cell” (IU Medical School-Lafayette) 3 credits (2007-2008) 
*Course Coordinator 
Public Presentations  
Past Seven Years 
“Discovery Park 2.0 – Creating Convergence”, September 2014 
“Drug Discovery at Purdue”, Women for Purdue, June 2014 
“Developing Better Medicine”, Summer Undergraduate Research Fellowship (SURF), College of 
Engineering, Purdue, June 2014 
“Women’s Innovations in Science and Engineering”, March 2014 
“Indiana CTSI – Engagement with IU Health Arnett”, CTSI Annual Retreat, April 2014 
“The Joy of Discovery”, Undergraduate Research Forum, April 2014 
“Purdue UMETRICS”, Federal Demonstration Partnership, Washington DC, January 2014 
“Entering the Era of Precision Medicine”, WGHI High Tea, September 2013  
“Developing Better Medicines”, Frankfort High School, 2013 
“Cancer Research at Purdue”, First Methodist Church, April 2013 
“Developing Better Medicine”, Summer Undergraduate Research Fellowship (SURF), College of 
Engineering, Purdue, June 2013  
“Personalized Medicine… It’s all about YOU”, Summer Undergraduate Research Fellowship 
(SURF), College of engineering, Purdue, June 13, 2012  
“Research… It Matters!”, Research Advocate Symposium, Discovery Park Purdue, March 9. 
2012 
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“Personalized Medicine and Cancer Treatment”, 2010 Midwest Oncology Nursing Symposium, 
STEW, October 21, 2010 
“Personalized Medicine… It’s all about YOU”, Science on Tap, Lafayette, IN, May 20, 2010  
“Cancer Research at Purdue,” Jackson County Purdue Alumni Club Annual Dinner, Logansport, 
IN, April 16, 2010 
“Cancer Research at Purdue,” Cass County Purdue Alumni Club Annual Dinner, Logansport, IN, 
June 9, 2009 
“Work/Family Life Balance and Mentoring/Career Advancement,” Pharmacy Women for Purdue 
Conference Panel, Purdue University, April 24, 2009  
“Conquering Cancer: Will Science Win?,” Keynote Speaker, Sigma Xi Annual Dinner, Purdue 
University, April 22, 2009 
“Purdue Cancer Center: Moving Toward a Cure,” Back to Class Purdue University, Naples, FL, 
February 14, 2009 
“Cancer Research at Purdue,” Department of Health and Kinesiology, Purdue University, 
November 5, 2008  
“Purdue Cancer Center: Moving Toward a Cure,” Back to Class, Purdue University, October 24, 
2008 
“Signaling from Golgi Membranes in T cells,” Frontiers in Biological Membranes Symposium, 
Purdue University Center for Basic and Applied Membrane Sciences, October 17, 2008 
“Cancer, New Thoughts on an Old Disease,” Keynote Speaker, Indiana Association of Family 
and Consumer Sciences, Centennial Meeting, Indianapolis, IN, September 25, 2008 
“New Approaches to Cancer Treatment, Early Detection, Individualized Care, Molecular 
Targeted Therapy, Genomics and Proteomics,” Hoosier Oncology Group, Inc. Educational 
Symposium, Purdue University, August 19, 2008 
“Research@Purdue: Discovery Park and Collaborations,” New Faculty Orientation, Purdue 
University, August 20, 2008 
“Cancer Research at Purdue,” Keynote Speaker, Annual Meeting, Purdue Alumni Club of 
Philadelphia, Philadelphia, PA, March 8, 2008 
 “Cancer Research at Purdue,” Keynote Speaker, Annual Meeting, Purdue Alumni Club of New 
York, New York, NY, March 9, 2008 
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